Oxidant effects on cultured cells of neural origin by Aito, Henrikka
O x i d a n t  e f f e c t s  
o n  c u l t u r e d  c e l l s  
o f  n e u r a l  o r i g i n
Henrikka Aito
Pediatric Graduate School
Hospital for Children and Adolescents
University of Helsinki
Finland
To be publicly discussed with the permission
of the Medical Faculty of the University of Helsinki,
in the Niilo Hallman Auditorium of the Hospital for Children and Adolescents,
on 11 September 2004, at 12 noon.
Helsinki 2004
ACADEMIC DISSERTATION
SUPERVISORS
Professor Kari O. Raivio
Hospital for Children and Adolescents
University of Helsinki
Helsinki, Finland
Kristiina Aalto, M.D., Ph.D.
Hospital for Children and Adolescents
University of Helsinki
Helsinki, Finland
REVIEWERS
Professor Eero Castrén,
Neuroscience Center
University of Helsinki
Helsinki, Finland
Docent Perttu Lindsberg
Department of Neurology
Helsinki University Central Hospital
Helsinki, Finland
OPPONENT
Professor Hannu Kalimo
The Haartman Institute
University of Helsinki
Helsinki, Finland
ISBN 952-91-7610-4 (paperback)
ISBN 952-10-2006-7 (PDF)
Yliopistopaino
Helsinki 2004
To Papu, Vertti, and Pete
CONTENTS
ORIGINAL PUBLICATIONS ............................................................................................6
ABBREVIATIONS................................................................................................................7
ABSTRACT...........................................................................................................................8
INTRODUCTION ..............................................................................................................9
REVIEW OF THE LITERATURE................................................................................... 10
1 PERINATAL  ASPHYXIA................................................................................................... 10
1.1 Clinical manifestations...............................................................................................................10
1.2 Ischemia/reperfusion .................................................................................................................10
1.3 Acute and delayed effects of cerebral ischemia/reperfusion............................................11
2 ENERGY METABOLISM OF NEURONAL CELLS ............................................................... 13
2.1 ATP synthesis..............................................................................................................................13
2.2 Interactions of high-energy nucleotides................................................................................14
3 REACTIVE OXYGEN SPECIES .......................................................................................... 14
3.1 Free radicals ................................................................................................................................14
3.2 Cellular sources of ROS...........................................................................................................15
3.3 ROS generation in vivo.............................................................................................................16
3.4 Antioxidant defenses.................................................................................................................16
4 INTRACELLULAR EFFECTS OF ROS EXPOSURE ............................................................ 17
4.1 Adenine nucleotide catabolism...............................................................................................17
4.2 Activation of protein kinases and transcription factors ....................................................17
4.3 Activation of poly(ADP-ribose) polymerase (PARP) .........................................................18
5 CELL DEATH................................................................................................................... 19
5.1 Modes of cell death ...................................................................................................................19
5.2 Execution of apoptosis..............................................................................................................19
5.3 Mitochondrial control of apoptosis .......................................................................................20
5.4 The Bcl-2 protein.......................................................................................................................21
6 OVERVIEW OF EXPERIMENTAL ASPHYXIA MODELS...................................................... 21
7 CLINICAL STRATEGIES FOR NEUROPROTECTION........................................................ 24
AIMS OF THE STUDY.................................................................................................... 26
MATERIALS AND METHODS...................................................................................... 27
8 OVERVIEW OF METHODS FOR STUDYING CELLULAR EFFECTS OF ROS .................... 27
8.1 Exogenous oxidants...................................................................................................................27
8.2 Adenine nucleotide depletion assay.......................................................................................27
8.3 Detection of the mode of cell death .....................................................................................28
9 METHODS USED IN THE CURRENT SERIES OF STUDIES ................................................ 28
9.1 Cell culture..................................................................................................................................28
9.1.1 Paju cells ...............................................................................................................................28
9.1.2 Rat embryonal cortical neurons......................................................................................28
9.2 Oxidant exposure......................................................................................................................29
9.3 Treatment with DPQ, α−ketoglutarate, or pyruvate........................................................29
9.4 Nucleotide depletion assay......................................................................................................29
9.5 Analysis of adenine nucleotides by HPLC ............................................................................29
9.6 Post-exposure adenine nucleotide synthesis .......................................................................29
9.7 Detection and  quantification of apoptosis ..........................................................................30
9.7.1 Analysis of DNA-degradation..........................................................................................30
9.7.2 Assessment of nuclear morphology ...............................................................................30
9.7.3 In Situ End-labeling of DNA (ISEL) .................................................................................30
9.8 Western blotting of PARP .......................................................................................................30
9.9 Protein analysis ...........................................................................................................................31
9.10 Cell counts ..................................................................................................................................31
9.11 Data analysis................................................................................................................................31
RESULTS............................................................................................................................. 32
10 OXIDANT EFFECTS ON HUMAN NEURAL CREST-DERIVED CELLS (I) .......................... 32
10.1 Nucleotide depletion ................................................................................................................32
10.2 Cell and DNA damage..............................................................................................................32
10.3 Correlation of EC with further growth................................................................................33
11 OXIDANT EFFECTS ON CULTURED CORTICAL NEURONS (II).................................... 33
11.1 Nucleotide metabolism.............................................................................................................33
11.2 Cell and DNA damage..............................................................................................................33
12 PREVENTION OF OXIDANT DAMAGE BY PARP-INHIBITION (III) .............................. 34
12.1 Nucleotide depletion ................................................................................................................34
12.2 Delayed effects ...........................................................................................................................34
13 EFFECTS OF EXTRACELLULAR GLUCOSE ON OXIDANT-INDUCED DAMAGE (IV) ..... 34
13.1 Nucleotide depletion ................................................................................................................34
13.2 Delayed effects of oxidant exposure.....................................................................................34
DISCUSSION..................................................................................................................... 36
CONCLUSIONS .............................................................................................................. 40
ACKNOWLEDGEMENTS ............................................................................................. 41
6ORIGINAL PUBLICATIONS
This thesis is based on the following original publications, which are referred to in the text by
their Roman numerals:
I. Aito H, Aalto K, and Raivio K. Correlation of oxidant-induced acute ATP depletion with
delayed cell death in human neuroblastoma cells. Am J Physiol. 1999 Nov;277(5 Pt 1):C878-C883.
II. Aito H, Aalto K, and Raivio K. Biphasic ATP depletion caused by transient oxidative
exposure is associated with apoptotic cell death in embryonal cortical neurons. Pediatric Research.
2002;52(1).
III. Aito H, Aalto K, and Raivio K. Adenine nucleotide metabolism and cell fate after oxidant
exposure of rat cortical neurons: Effects of inhibition of poly(ADP-ribose) polymerase. Brain Res.
2004 Jul 2;1013(1):117-24.
IV. Aito H, Aalto K, and Raivio K. Effects of extracellular glucose concentration on oxidant-
induced ATP depletion. Submitted 2004.
The copyright owners have kindly granted permission to reproduce the original articles.
7ABBREVIATIONS
AIF apoptosis-inducing factor
APAF-1 apoptotic protease activating factor 1
CAD caspase activated deoxyribonuclease
CASP-1 to CASP-10 caspases 1-10
CAT catalase
CuZnSOD copper-zinc superoxide dismutase
cyt c cytochrome c
dATP 2'-deoxyadenosine 5'-triphosphate
DCFH-DA 2’,7’-dichlorofluorescin dihydroacetate
DMEM  Dulbecco's modified Eagle's medium
DPQ 3,4-Dihydro-5-[4-(1-piperidinyl)butoxy]-1(2H)-isoquinolinone
dUTP deoxyuridine triphosphate
EC adenylate energy charge
eNOS endothelial nitric oxide synthase
GPx glutathione peroxidase
GSH glutathione, reduced
GSSG glutathione, oxidized
HIE hypoxic-ischemic encephalopathy
IL-1β interleukin-1β
iNOS inducible nitric oxide synthase
ISEL in situ end labeling
ITFs inducible transcription factors
JNK c-Jun NH2-terminal kinase
MAPK mitogen-activated protein kinase
MEKK1 MAPK/ERK kinase kinase 1
MnSOD manganese superoxide dismutase
MRS magnetic resonance spectroscopy
NF-κB transcription factor nuclear factor-kappa B
NGF nerve growth factor
NMDA glutamate agonist N-methyl D-aspartate
nNOS neuronal nitric oxide synthase
NO. nitric oxide
NOS nitric oxide synthase
O2- superoxide anion
OH. hydroxyl radical
ONOO_ peroxynitrite
PARP poly(ADP-ribose) polymerase
PBS phosphate buffered saline
PC12 undifferentiated pheochromocytoma cell line
PCr phosphocreatine
PMA phorbol 12-myristate 13-acetate
PRPP phosphoribosyl pyrophosphate
PT permeability transition
PVL periventricular leucomalacia
ROS reactive oxygen species
SAPK stress-activated protein kinase
SOD superoxide dismutase
TdT terminal deoxynucleotidyl transferase
TLC thin layer chromatography
TNF-α tumor necrosis factor α
XOR xanthine oxidoreductase
α−kg alpha-ketoglutaric acid
∆Ψm mitochondrial transmembrane potential
8ABSTRACT
In this series of studies, cultured cells of neural origin were exposed to a transient oxidant
insult to assess its acute effects on cellular adenine nucleotide content and adenylate energy
charge. The acute adenine nucleotide depletion was correlated to further ATP synthesis, cell
viability, mode of death, cellular and nuclear morphology, as well as to the cleavage of a
nuclear DNA-stabilizing enzyme, poly(ADP-ribose) polymerase (PARP). The effects of
overexpressing an anti-apoptotic protein Bcl-2, of inhibiting PARP, and of modulating the
levels of extracellular glucose on acute and delayed oxidant injury were also evaluated.
The adenylate energy charge (EC) after a transient exposure to H2O2 correlated well with
further growth of cultured neural crest-derived cells. A significant decline in  EC led to
delayed cell death. Overexpression of Bcl-2 did not protect against the fall in EC or adenine
nucleotide depletion, but although survival was not improved, the mode of death appeared
to be different from wild type cells, which mostly died by apoptosis-related mechanisms.
In cultured cortical neurons from rat embryos, a mild oxidative insult had no effects on
nucleotides nor subsequent growth, whereas a moderate insult caused acute ATP depletion
to 49±12% of control, which  recovered to 91±28% by 12 h, but then declined to 61+18%
at 24 h. A severe insult (1 mM H2O2) depleted ATP to 15±3% of control, with no recovery.
Moderate ATP depletion was associated with apoptotic-type cell death, whereas a severe
insult caused acute necrosis.
Comparing neurons exposed to H2O2 with or without the PARP inhibitor 3,4-Dihydro-5-[4-
(1-piperidinyl)butoxy]-1(2H)-isoquinolinone (DPQ), DPQ elevated ATP levels, modulated
the mode of cell death, and improved cell counts. In cells challenged with a severe insult,
ATP depletion to 18±4% was associated with necrosis and intact PARP. In these cells, DPQ
elevated ATP to a ‘moderate’ level (ATP 44±12 % of control), improved cell counts,
enhanced DNA fragmentation, and brought about PARP cleavage. Post–insult application of
DPQ was also partly effective.
When neurons were exposed to H2O2 in the absence of extracellular glucose, th acute
H2O2-induced ATP depletion and the extent of cell death were exacerbated. Addition of α-
ketoglutarate and pyruvate to the culture medium after the oxidative exposure significantly
improved cellular morphology and viability at 24 h in the neurons exposed to H2O2 in the
absence of glucose. Simple temporary absence of glucose or acute ATP depletion induced by
inhibition of glycolysis for 60 min had no acute nor delayed effects on the cells. Increasing
the extracellular glucose to 33 mM did not aggravate the acute oxidative insult.
In conclusion, these results demonstrate that the depth of acute oxidant-induced adenine
nucleotide depletion correlates with the mode of ensuing cell death. In rat cortical neurons,
a transient oxidant exposure causes a biphasic energy depletion associated with delayed cell
death, in analogy with asphyxiated brains. The severity of the acute depletion can be
alleviated by inhibiting the ATP-consuming enzyme PARP and by modifying the concentration
of extracellular glucose, but not by overexpression of Bcl2-protein. The delayed effects of a
transient oxidative exposure can to some extent be reversed by inhibition of PARP or post-
insult application of α−ketoglutarate.
This model of cultured neuronal cells and the method of prelabeling the cells with a high-
energy nucleotide precursor proved a sensitive tool for exploring the acute and delayed
effects of graded oxidative exposures on cellular energy metabolism in vitro, as well as for
studying potential approaches to neuroprotection.
9INTRODUCTION
Perinatal brain damage due to asphyxia is a leading cause of permanent neurological deficits.
Animal models show that asphyxia results in an acute decline in cerebral energy metabolism
and that, upon reperfusion, the disturbance of cerebral energy status may be gradually
corrected. However, in severe cases, a recurring energy depletion occurs during the next
12 to 48 h, followed by postasphyxial brain damage or death. The restoration of circulation
and oxygen supply to tissues is associated with generation of reactive oxygen species (ROS),
which can exacerbate the developing injury.
That the degree of the neurological injury is dependent on the severity of the initial insult as
well as on the maturation stage of the brain has been documented both in clinical medicine
and in animal models, but the exact mechanisms by which a transient ischemic insult leads to
impairment of high-energy nucleotide metabolism and neuronal death remain unsolved. Low
levels of circulating glucose, which often accompany perinatal asphyxia, may further
complicate the recovery phase.
The biphasic energy depletion and the delayed course of the post-asphyxial neuronal damage
apparently offer a ‘window of opportunity’, during which methods could be devised to
modify or prevent the detrimental outcome. Unfortunately, there are currently few effective
means for prevention of hypoxic-ischemic encephalopathy (HIE) associated with asphyxia.
This series of studies using cultured cells was aimed at investigating the mechanisms and
consequences of oxidant-induced neuronal injury, with an emphasis on the cellular energy
metabolism. In addition, possibilities of preventing delayed neuronal death associated with a
transient oxidant exposure were assessed.
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REVIEW OF THE LITERATURE
1 PERINATAL  ASPHYXIA
1.1 Clinical manifestations
Asphyxia is a major cause of perinatal death
and permanent postnatal neurological
disabilities such as cerebral palsy. The term
asphyxia generally refers to an impairment in
the exchange of respiratory gases during birth,
resulting in hypoxemia and hypercarbia,
combined with bradycardia and/or
hypotension, causing global cerebral ischemia
(Hill and Volpe 1982, Berger and Garnier
1999). In the central nervous system (CNS),
asphyxia followed by reperfusion may result in
hypoxic-ischemic encephalopathy (HIE),
which is characterized by a wide spectrum of
relatively well-defined neurological and
neuropathological  abnormalities. The severity
of the acute symptoms and of the ensuing
neurological complications depends on the
duration and extent of the insult as well as on
the maturation stage of the brain. In term
babies, magnetic imaging studies show
prominent and selective bilateral neuron loss in
hippocampal and central cortico-subcortical
regions, with additional damage in putamen,
cerebellum and the anterior horn of the spinal
cord (Rademakers et al. 1995). The
corresponding clinical manifestations include
as weakness of the proximal extremities, and
possible long-term motor or intellectual
deficits. In preterm neonates, periventricular
white matter is most often damaged, and the
resulting clinical entity, periventricular
leucomalacia (PVL), is characterized by spastic
diplegia  (Hill and Volpe 1982). In all infants,
HIE increases susceptibility to seizures
(Johnston et al. 2001).
The incidence of postasphyxial neurological
complications correlates inversely with
gestational age (Tin et al. 1997). In Finland, the
overall incidence of cerebral palsy is 0.46%,
but it reaches 18% in infants weighing less
than 1000 g at birth (Salokorpi 1999). In term
infants, prenatal causes, such as maternal
disease, malformation syndromes and
congenital infections account for 30% of the
cases (Wu et al. 2003), whereas 25% are
attributable to asphyxia (Salokorpi 1999). In
preterm infants, prenatal causes for
neurological deficits are less frequent (Paneth
1993).  Clinical findings associated with
increased risk for perinatal HIE include
progressive heart rate abnormalities before
birth, and severe cardiovascular depression
manifested as very low Apgar score at 5-15
min, acidosis, and requirement of major
resuscitation at birth (Vannucci and Perlman
1997).
1.2 Ischemia/reperfusion
Deprivation of oxygen and glucose during
cerebral ischemia, such as perinatal asphyxia,
impairs cellular oxidative phosphorylation and
leads to a mismatch in the synthesis and
continuing utilization of high-energy
phosphates, i.e. phosphocreatine (PCr),
adenosine triphospate (ATP), and adenosine
diphosphate (ADP) levels. The lack of oxygen
in a neuron can initially be compensated by
increasing anaerobic glycolysis, with
concomitant generation of lactate and
increasing tissue acidosis. With prolonging
ischemia, however, the capacity of a cell to
maintain ATP levels and subsequently ionic
gradients, particularly that of Ca2+, across the
cell membrane is compromised. In some
neurons, this leads to release of glutamate, the
main excitatory transmitter of the CNS.
Overactivation of post-synaptic neuronal N-
methyl-D-aspartate (NMDA)- and other
glutamate-activated receptors controlling
membrane-associated ion channels provokes
massive influxes of Na+- and Ca2+-ions
causing depolarization and by osmotic
swelling, disruption of the neuron (Bear et al.
2001). This event, known as excitotoxicity is
associated with numerous cellular events,
including increased production of ROS,
namely superoxide (O2.-), hydrogen peroxide
(H2O2), and peroxynitrite (ONOO_), through
activation of several calcium-dependent
enzymes (Dawson et al. 1991, Lafon-Cazal et
al. 1993). Glutamate toxicity is self-
propagating, as its release is increased also in
the post-synaptic neuron.
11
The acute, yet potentially non-lethal effects of
short-term ischemia may be considerably
aggravated during the reperfusion phase,
mainly because of generation of ROS. This is
indicated by experiments in which reperfusion
with deoxygenated blood does not increase
damage caused by ischemia alone (McCord
1985, Granger et al. 1986). ROS have multiple
acute and delayed effects on cellular function
and they are important promoters of the
inflammatory response. The expression of
adhesion molecules and chemotactic factors is
elevated, followed by recruitment of microglia
and adherence on endothelium of
granulocytes, which later migrate into brain
parenchyma.  These events further amplify
ROS production (Matsuo et al. 1995, Lerouet
et al. 2002). In the CNS, generation of ROS
during reperfusion has been documented by
spin-trapping and direct electron paramagnetic
resonance techniques (Zini et al. 1992,
Hasegawa et al. 1993, Phillis and Sen 1993).
1.3 Acute and delayed effects of
cerebral ischemia/reperfusion
Localized cerebral ischemia induces tissue
infarction, which manifests itself as neuronal
and glial cell necrosis (see below) in the
affected area progressing in minutes to hours.
After reperfusion, the core lesion will be
surrounded by a ‘penumbra’, a transitional
zone, in which cells undergo delayed neuronal
death following a longer time course. In
global ischemia, such as neonatal asphyxia,
where the duration of the ischemia
determines the extent of the cerebral injury,
selective delayed neuronal death is an active
programmed process with apoptotic (see
below) characteristics, although during and
shortly after an ischemic insult some of the
neurons may die by necrosis (Heiss et al.
1992).
Animal models of asphyxia show that the
circulatory failure is initially compensated by
vasodilatation and reactive hyperemia, but
with increasing duration of ischemia
autoregulatory mechanisms are lost and
cerebral blood flow diminishes (Berger and
Garnier 1999). Immature fetuses have
particularly limited autoregulatory capacity to
compensate for ischemia (Berger and Garnier
1999). Increased permeability of the cerebral
vascular bed and disruption of the blood-
brain barrier follow abolished vascular
autoregulation. These changes are largely
mediated by ROS generation and they lead to
brain edema (Yang et al. 1994, Fellman and
Raivio 1997). After resuscitation, a transient
period of reactive hyperperfusion is often
present in asphyxiated infants developing
brain injury, but this is accompanied by
decreased cerebral oxygen extraction, and by
the end of the first postnatal week, areas of
hypoperfusion develop in the cortical areas
parallel to the central sulcus (Fellman and
Raivio 1997). The relative vulnerability of
certain brain regions is not fully understood,
as their pattern is not related to the regional
vascular distribution, but may rather be
explained by high intrinsic vulnerability of the
areas with high metabolic activity
(Rademakers et al. 1995). As for the
development of PVL in asphyxiated preterm
neonates, the progenitor cells for myelin
producing oligodendrocytes may play a
central role in propagating the neuronal
damage (Rezaie and Dean 2002).
A transient global ischemic insult leads also to
a rapid decline in cerebral oxidative
phosphorylation, first reflected in a decrease
of the ratio of phosphocreatine to Pi
(PCr/Pi), measured by magnetic resonance
spectroscopy (MRS) in a neonatal rabbit
asphyxia model (Delpy et al. 1982).
Subsequently, cellular ATP levels become
depleted. Upon reperfusion, the energy status
is initially restored, but after a delay of several
hours shows progressive secondary failure
associated with brain damage or death. The
severity of the outcome correlates with the
degree of the initial energy depletion but is
not associated with a decrease in intracellular
pH nor recurring hypoxia (Lorek et al. 1994,
Penrice et al. 1997). The number of apoptotic
and necrotic cells in the piglet brain at 48 h
correlates with the degree of high-energy
phosphate depletion during the primary insult
(Mehmet et al. 1994), and the extent of the
delayed impairment of energy metabolism is
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related to the magnitude of cerebral infarction
in developing rats (Blumberg et al. 1997).
The intensity of the acute insult may
determine not only the extent but also the
mechanism of the postischemic neuronal
damage. In an immature rat model, the
neuronal death caused by a brief ischemic
period is mostly accounted for by apoptosis,
while severe ischemia is associated with
immediate or delayed necrosis (Beilharz et al.
1995).
In general, the ratio of apoptotic to necrotic
cells in the asphyxiated neonatal brain is
considered substantially greater than in adults
following cerebral ischemia (Johnston et al.
2001), and the process of post-ischemic
neuronal destruction is more rapid than in
adults (Vannucci and Perlman 1997). In vitro,
depending on the severity of the insult, an
excitotoxic insult can either lead to necrosis
or initiate apoptosis (Kure et al. 1991,
Ankarcrona et al. 1995, Bonfoco et al. 1995).
In human infants, determination of
immediate asphyxia-related events in the CNS
is not possible for ethical and technical
reasons.
When monitored at 2-4 h after resuscitation,
infants developing postasphyxial brain
damage show normal MRS findings.
However, at 12 to 24 h a secondary energy
collapse is detected (Azzopardi et al. 1989).
The depth of this delayed metabolic
derangement in the newborn brain correlates
significantly with later outcome of brain
development (Roth et al. 1992).
Table 1. Characteristics of immature CNS that
influence vulnerability to asphyxia.
Limited capacity for vascular autoregulation.
Susceptibility of myelin producing
oligodendrocyte progenitors to ischemic damage.
Limited antioxidative capacity and relatively high
free iron content.
Limited capacity for cerebral glucose uptake.
Rapid progression of ischemic neuronal damage
compared to adult CNS.
Low circulating levels of glutathione and
transferrin.
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2 ENERGY METABOLISM OF
NEURONAL CELLS
2.1 ATP synthesis
Adequate reserves of cellular energy, mainly in
the form of ATP, are essential, not only to
ensure basal cellular functions, but also to
maintain the resting membrane potential
requisite for neuronal signaling and cell
integrity. This is achieved by a functional
sodium-potassium pump (Na+/K+-ATPase)
which consumes ca. 70% of the total ATP
used by the CNS (Bear et al. 2001). In a
neuron having no glycogen reserves,
extracellular glucose is the main fuel to
generate ATP, but during fasting and the
suckling period, also ketone bodies derived
from fatty acids in the liver can be processed
to enter the citric acid cycle (Hawkins et al.
1971, Izumi et al. 1998). In addition, all of the
end-products of amino acid catabolism are
able to enter the citric acid cycle. The brain
uptake of the ketone bodies and amino acid
degradation products is in direct proportion to
their plasma concentration, and can during
suckling substitute for up to 20% of the total
energy production  (Vannucci and Vannucci
2000).
In situations where the availability of glucose
or oxygen is limited, the capacity of glucose
transport into brain is of particular importance.
Glucose is transported across the blood-brain
barrier via an energy-independent but saturable
form of facilitated transport (Fishman 1964).
During asphyxia the energy metabolism shifts
to anaerobic glycolysis, an inefficient way to
produce  energy. The accumulating lactate
leads to increasing tissue acidosis, which
aggravates oxidant-induced cell injury (Ying et
al. 1999). As the cerebral glucose uptake
capacity of the newborn rat is only 20% of the
adult rate, glucose supplementation will not
directly enhance energy production. In view of
that, also the accumulation of lactate and
ensuing acidosis in the newborn brain during
asphyxia are less severe than in adult animals
(Vannucci and Vannucci 2000). Studies on
animals suggest, however, that also lactic acid
can be used as an alternative fuel by the
immature brain (Vannucci and Vannucci
2000).
Figure 1: A schematic diagram of the metabolic pathways of ATP synthesis. Glucose metabolism to yield ATP occurs in three
main processes. The first, cytoplasmic glycolysis, does not require oxygen and leads to formation of pyruvate and in the
absence of oxygen, lactate. The ATP yield of glycolysis is scarce, requiring an investment of two ATP molecules for a return
of four. The second phase, the citric acid cycle, which pyruvate enters after being converted to acetyl-coenzyme-A, results in
generation of reducing equivalents (NADH and FADH2), which are in the third phase oxidized with concomitant reduction of
oxygen in the mitochondrial electron transfer chain, a process that ultimately yields 25 molecules of ATP for one molecule of
glucose. Products of fatty acid oxidation and degradation products of amino acids are also able to enter the citric acid cycle
after being transported into mitochondria.
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2.2 Interactions of high-energy
nucleotides
The parent nucleotide of ATP is adenylate, or
adenosine 5’-monophosphate (AMP), which
can be phosphorylated to ADP by the
cytoplasmic adenylate kinase. This reaction is
fully reversible, and accumulating ADP will be
removed (Fig. 2a). The metabolic conditions of
the cell determine the relative concentrations
of adenine nucleotides, so the phosphoryl
groups and high-energy bonds are under
constant, dynamic modification.
Phosphocreatine (PCr), present also in the
brain, serves as a reservoir of phosphoryl
groups and a quick source for replenishment
of ATP (Fig 2b). When the cellular energy
demands are not met and build-up of AMP
occurs, adenylate is either dephosphorylated to
adenosine by 5’-nucleotidase, or converted to
inosine monophosphate (IMP) to be
catabolized to inosine and on to hypoxanthine,
which by the action of xanthine
oxidoreductase (XOR) ultimately yields uric
acid (Fig. 2c).
a. ADP + ADP ATP + AMP
ATP + Crb. ADP + PCr
ATP
ADP
AMP
adenosine
inosine
IMP
hypoxanthine
xanthine
uric acid
c.
XOR
XOR
Figure 2: Interactions and catabolism of high-energy adenine nucleotides.
3 REACTIVE OXYGEN SPECIES
3.1 Free radicals
A free radical is, by definition, any
independently existing atom or molecule that
possesses one or more unpaired electrons
(Halliwell and Gutteridge 1989). Free radicals,
such as ROS, are capable of reacting with
other molecules by multiple mechanisms,
usually in a way that generates more radicals
and adduct products. The consequences of
free radical reactions include translational
errors, DNA fragmentation, lipid peroxidation
and cross-linking, modifications in enzyme
functions, as well as alterations in membrane
permeability and protein structure, all of which
are potentially detrimental (Halliwell and
Gutteridge 1989). Due to propagation of
reactions via free radical intermediates, the
potential damage is amplified by a cascade
mechanism (Freeman and Crapo 1982).  At
lower, physiological levels, ROS serve as
second messenger molecules participating in a
wide variety of normal cellular functions, such
as regulation of cytokine and growth factor
actions, ion transport, transcription, and
neuromodulation (reviewed by (Lander 1997)).
A cell is protected from excessive ROS
formation by a battery of antioxidative
enzymes, non-enzymatic antioxidant
molecules, and enzymes capable of reversing
oxidant induced cellular damage.  Enhanced
production of ROS that exceeds the cell’s
antioxidative protection capacity, but will not
cause its immediate destruction, activates
enzymes and transcription factors that may
either promote survival or actively lead to cell
death.
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3.2 Cellular sources of ROS
Cellular respiration involves the reduction of
molecular oxygen to water by the simultaneous
oxidation of NADH to NAD+. If only partially
reduced, oxygen forms reactive metabolites,
such as O2.-, H2O2, or hydroxyl anion (OH.).
In normal cellular metabolism ca. 1-3% of the
electron flow is estimated to escape the
respiratory chain (Boveris et al. 1972:
Fridovich, 1978 #126). However, if the
components of the respiratory chain are in an
excessively reduced state or damaged, a state
referred to as mitochondrial dysfunction, the
proportion is thought to be substantially larger.
This may occur during hypoxia, in the
reperfusion phase following ischemia or in
hyperoxia, or be due to chemicals affecting the
respiratory chain enzymes (Boveris et al. 1972).
Hypoxia accelerates the rates of O2.- and H2O2
production primarily at the respiratory chain
complexes I and III (Freeman and Crapo 1982,
Gonzalez-Flecha and Boveris 1995, Chandel et
al. 1998).
Other sites of intracellular O2.- generation
include the plasma and nuclear membranes as
well as the endoplasmic reticulum where
cytochrome P450- and b5-related mixed
function oxidases  directly form O2.- and H2O2.
ROS are also generated by oxidase enzymes,
e.g. peroxisomal fatty acyl CoA-oxidase,
membrane-bound NAPDH oxidase (present
also in neurons) (Tammariello et al. 2000), and
cytoplasmic xanthine oxidoreductase (XOR)
(Granger 1988). There is no direct evidence of
XOR being responsible for reperfusion injury
in brain, although its immunolocalization in
human capillary endothelium (Moriwaki et al.
1993, Linder et al. 1999) and alleviation of
ischemic brain damage by allo- and oxypurinol,
its specific inhibitors (Phillis and Sen 1993,
Palmer 1995, Van Bel et al. 1998), make this a
possibility. During ischemia/reperfusion, O2.-
is generated also during arachidonic acid
metabolism by activated lipoxygenase
(Moskowitz et al. 1984).
Another important ROS, NO. is produced by
the three isoforms of the enzyme nitric oxide
synthase (NOS) (Beckman et al. 1990).  In the
CNS, at physiological concentrations, NO. is a
neuromodulator in addition to its other roles
as a vasodilatator and an effector of the
immune system. In certain pathophysiological
states, such as hypoxia-ischemia, excess
amounts of NO. are formed, first by Ca2+-
activated nNOS, and then, after an induction
delay, at a higher rate by iNOS (reviewed in
(Dawson and Dawson 1996)). In general, NO.
is considered a beneficial physiological
mediator in the vascular compartment, but
toxic when formed in the brain parenchyma.
As an uncharged molecule, NO. is not
particularly reactive by itself, but with O2.- it
readily forms peroxynitrite (ONOO-), a potent
oxidant capable of disrupting several cellular
functions (Beckman et al. 1990, Brorson et al.
1999).  Glutamate toxicity, for instance, is
considered primarily to be mediated by
induction of NOS and concomitant
production of ONOO-, although inhibition of
cystine uptake and subsequent decrease in
cellular glutathione levels are contributing
mechanisms (Murphy et al. 1989, Pereira and
Oliveira 1997).
Of the different ROS, OH. is the most
reactive. It is produced by reactions of O2.- and
H2O2 in biological systems in the presence of
transition metals, such as ferrous iron and
copper (Halliwell and Gutteridge 1989).
H2O2, although not a free radical by definition,
is a potential source of O2.-. It can freely cross
biological membranes and has signaling
functions per se (Suzuki et al. 1997). An
increase in mitochondrial O2.- production leads
to an increase in H2O2 steady-state
concentration in the whole cell (Gonzalez-
Flecha et al. 1993).
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Figure 3: Cellular sources of reactive oxygen species, their formation and interconversions, and the location of the main
antioxidant enzymes.
3.3  ROS generation in vivo
Generation of ROS during the first minutes of
reperfusion has been shown by spin trapping
and electron paramagnetic resonance
techniques in animal cerebral
ischemia/reperfusion models in vivo (Zini et al.
1992, Hasegawa et al. 1993, Phillis and Sen
1993, Piantadosi et al. 1995, Bågenholm et al.
1998). In most studies, the peak of OH.
generation occurs during the early
reoxygenation phase, but increased formation
of O2.- has also been shown to coincide with
delayed neuronal damage during the first days
after asphyxia. A major site of ROS production
is believed to be the vascular endothelium,
although some may arise from brain
parenchyma (Zini et al. 1992). The H2O2
concentrations during  reperfusion at one hour
after forebrain ischemia, in samples collected
by microdialysis, have been shown to be
approximately 100 µM  (Hyslop et al. 1995).
3.4 Antioxidant defenses
In a cell, most of the O2.- produced is
converted into H2O2 by the antioxidant
enzymes manganese superoxide dismutase
(MnSOD) and copper-zinc SOD (CuZnSOD),
and on to H2O by catalase (CAT) and
glutathione peroxidase (GPx). At low,
physiological concentrations, and in the CNS,
GPx (a group of enzymes) is considered the
primary antioxidant defense against H2O2
(Halliwell and Gutteridge 1989), although in
neurons CAT contributes significantly to
peroxide decomposition (Dringen et al. 1999).
GPx catalyzes the reduction of peroxides to
water by oxidizing glutathione (GSH) to its
oxidized form, GSSG, in the glutathione redox
cycle GSH is regenerated by glutathione
reductase at the expense of reducing
equivalents from NADPH.
There is no enzymatic protection against OH.
other than controlling the environmental
conditions favoring its formation from O2.-.
An important means of achieving this is by
limiting the concentration of free iron, which is
the function of the iron binding proteins,
ferritin and transferrin (Halliwell and
Gutteridge 1989). The removal of O2.- by the
SODs also acts  as an effective protection
against formation of  ONOO- (Beckman and
Koppenol 1996).
In addition to enzymes, a cell is protected
against ROS by non-enzymatic antioxidants,
which function by scavenging free radicals in
distinct cellular compartments to terminate
free radical propagation. Besides GSH, these
include β-carotene, α-tocopherol, ascorbic
acid, and uric acid (Halliwell and Gutteridge
1989).
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4 INTRACELLULAR EFFECTS OF
ROS EXPOSURE
4.1 Adenine nucleotide catabolism
Exposure to ROS causes a rapid decrease in
cellular ATP levels (Ager and Gordon 1984,
Spragg et al. 1985, Andreoli 1989), which may
be due either to ATP degradation or efflux of
nucleotides from cells. Oxidants also impair, or
directly inhibit, the function of the
mitochondrial respiratory chain complexes,
and the consequent mitochondrial dysfunction
decreases ATP production and increases ROS
generation (Hyslop et al. 1988, Brorson et al.
1999, Almeida and Bolanos 2001). Moreover,
in the absence of oxygen the mitochondrial
ATP synthase may function in reverse,
hydrolyzing ATP in order to preserve the
mitochondrial membrane potential (∆Ψm) (Di
Lisa and Bernardi 1998). H2O2 also inhibits
glycolytic ADP phosphorylation (Hyslop et al.
1988). During prolonged ROS exposure a
critically low intracellular concentration of
high-energy nucleotides may be reached, after
which cell injury becomes irreversible (Hyslop
et al. 1988). Disturbances in mitochondrial
function and ATP synthesis have been
associated with the onset of apoptosis
(Armstead et al. 1988, Marton et al. 1997,
Almeida and Bolanos 2001). A permanent
energy failure may cause necrosis, whereas cells
retaining the potential to produce high-energy
phosphates have been shown to pass on to
apoptosis more readily. In the absence of
cellular ATP the apoptotic program can switch
to necrosis (Eguchi et al. 1997, Leist et al.
1997, Lelli et al. 1998, Volbracht et al. 1999).
4.2 Activation of protein kinases
and transcription factors
Responses to intra- or extracellular stimuli,
such as ROS, are conducted throughout the
cell via signaling pathways, many of which
function by recruitment of protein kinases or
phosphorylases that in turn phosphorylate or
dephosphorylate other kinases or cellular
proteins in a cascade mechanism. ROS may
modulate kinase activity also by direct redox-
regulation (Lander 1997). At least two major,
partly overlapping, classes of signal
transduction pathways have been
characterized. The MAPK or mitogen-
activated protein kinase pathway responds
mainly to mitogenic stimuli such as growth
factors or phorbol esters, and moderately to
H2O2 and Ca2+ (Kyriakis et al. 1994). c-Jun
NH2-terminal kinases or JNKs, also termed
stress-activated protein kinases or SAPKs, are
activated by inflammatory cytokines (TNF-α
or IL-1β),  or cellular stress (e.g. ROS, UV-
radiation, heat shock) (Kyriakis et al. 1994);
reviewed in (Kyriakis and Avruch 1996). A
complexly regulated kinase cascade directly
involved with the execution of oxidative stress-
induced apoptotic cell death, intertwining with
the JNK pathway, is initiated by the mitogen-
activated protein kinase kinase kinase 1
(MEKK1). MEKK1 itself is caspase-activated
and a potent inducer of  apoptosis (Widmann
et al. 1998, Gibson et al. 2002).
‘Sounding of alarm’ by the kinases leads to a
rapid and transient activation of inducible
transcription factors (ITFs), coded for by
genes that regulate subsequent gene expression
by their protein products’ binding to DNA.
The responses to oxidative stress may serve
adaptation, promote survival, or lead to
delayed cell death. The expression of specific
ITFs is dependent on the degree of the insult
and the transcriptional effects on DNA-
binding of the combination of ITF protein
dimers (Hai and Curran 1991). Numerous ITF
target genes associated with delayed neuronal
death, or apoptosis, have been hitherto
characterized. The first ITF shown to respond
directly to oxidative stress was NF-κB, a
ubiquitous regulator of multiple target genes
involved in immune or inflammatory
processes. In the CNS, NF-κB participates in
neuronal development, plasticity, and
neurodegeneration (O'Neill and Kaltschmidt
1997). Therefore, in most paradigms, such as
following transient hypoxia, NF-κB activation
is considered anti-apoptotic, leading to
increased expression of at least bcl-2 and bcl-x
(Tamatani et al. 1999). On the other hand,
blocking activation of NF-κB by aspirin after
an excitotoxic insult has been shown to be
neuroprotective (Grilli et al. 1996). Also,
transient focal ischemia leads to concomitant
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nuclear translocation of NF-κB and activation
of c-myc and p53, well characterized
apoptosis-associated genes (Morrison and
Kinoshita 2000, Huang et al. 2001). Both of
these phenomena are down-regulated by
overexpression of CuZnSOD, which decreases
ischemic brain damage in vivo (Chan et al.
1998).
4.3 Activation of poly(ADP-ribose)
polymerase (PARP)
PARP is an abundant nuclear enzyme, the
main function of which is to assist DNA repair
by stabilizing DNA (Virag and Szabo 2002).
PARP is rapidly activated as a stress response
to DNA-damaging stimuli, particularly to
oxidative stress (Schraufstatter et al. 1986).
Upon activation, it attaches to a strand break
site and catalyses extensive formation of long
poly-(ADP-ribose) polymers onto nuclear
proteins and itself by employing NAD+ as the
precursor. In the case of  strong activation, the
NAD+-consumption leads to exhaustion of
ATP and other energy substrates, which
potentially results in necrotic cell death
(Schraufstatter et al. 1986, Ha and Snyder
1999). In the case of a major DNA-damaging
insult, this may be an appropriate method for
disposal of damaged genetic material.
Activation of PARP has been shown also to
induce the release of apoptosis-inducing factor
(AIF) from mitochondria (Yu et al. 2002).
Under controlled circumstances, auto-poly-
ADP-ribosylation of PARP leads to its
dissociation from DNA, thus downregulating
its activity and allowing for subsequent binding
of DNA-reparative enzymes. The original
form and binding properties of PARP are
restored by poly-(ADP-ribose) glycohydrolase,
which concomitantly removes polyribose
chains at a slower rate (1–2 min) (Lindahl et al.
1995). Following a sublethal acute stimulus, as
in the early phases of apoptosis, PARP can be
inactivated by caspase cleavage to two
fragments:  A larger (85-89 kDa) and a smaller
aminoterminal fragment (24-31 kDa)
(Lazebnik et al. 1994). This is thought to
inhibit the exhaustion of ATP and restore
energy for apoptosis to proceed  (Ha and
Snyder 1999, Herceg and Wang 1999).
Figure 4: Intracellular effects of ROS
exposure. Intra- or extracellularly
generated ROS potentially trigger a vicious
cycle leading either to apoptotic or
necrotic cell death. The mode of cell death
is dependent, among other factors, on the
gravity of the initial insult and ensuing
energy depletion. A cell may survive a mild
insult by induction of adaptive processes.
See text for details.
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5 CELL DEATH
5.1 Modes of cell death
Apoptosis, or programmed cell death, is an
active, energy-consuming regulatory process
for removing excess, aged, or damaged cells
(Wyllie et al. 1980). Apoptosis is essential for
organogenesis and tissue homeostasis, but it
can represent and unwanted response of the
cell to noxious stimuli. Although apoptosis is
often referred to as endogenous ‘cell suicide’,
in many experimental systems the process can
be initiated by external influences. In addition
to oxidative stress, well known inducers of the
apoptotic program include receptor-binding
ligands such as Fas or TNF-α. Other, non-
specific inducers are gamma- or UV-
irradiation, glucocorticoids, cytokines, heat
shock, chemotherapeutic agents, viral infection
and matrix detachment (reviewed in
(Thompson 1995)). Neuronal survival is
absolutely dependent on trophic support, and
in neuronal in vitro systems NGF-deprivation
induces apoptosis. Conditions mimicking
hypoxia-reoxygenation, exposure to oxidative
stress or to NMDA-antagonists, and
experimental axotomy have also been used in
neuronal apoptosis models (Pettmann and
Henderson 1998). Although apoptotic cells
have distinct morphological characteristics, it
has emerged that there are multiple intertwined
as well as separate effector pathways
depending on the stimulus and cell type in
question. Describing cellular events during
apoptosis requires understanding of the
experimental system, and few generalizations
can actually be made with confidence.
Necrosis, cell death by lysis, in contrast to
apoptosis, occurs in a disintegrated pattern in
cells exposed to overwhelming extracellular
stimuli or extreme ATP-depleting conditions
(Buja et al. 1993). Necrotic cells undergo
disruption of the plasma membrane and
organelle swelling, which often provoke
inflammation in the surrounding tissues. As a
passive process, necrosis does not require
energy, protein synthesis, or coordinated
regulation. In most whole organ paradigms,
however, especially in the CNS, the classic
types of cell death, apoptosis and necrosis,
occur simultaneously, and individual dying
cells cannot be classified unequivocally, as
some programmed cell death patterns end up
with necrotic morphology (Pettmann and
Henderson 1998, Lemasters 1999). Also
excitotoxic neuronal death in vitro has
ultrastructural features consistent with both
apoptosis and necrosis (Hou and MacManus
2002).
5.2 Execution of apoptosis
The principal morphological signs of apoptosis
are blebbing of the plasma membrane,
cytoskeletal disruption, condensation of
nuclear chromatin, and fragmentation of
nuclear DNA, first to approximately 300-kb
segments, subsequently to 50-kb and finally to
small, ca. 185 bp internucleosomal fragments.
At later stages, cytoplasm and nucleus form
membrane-bound apoptotic bodies, which are
engulfed by neighboring cells or tissue
macrophages without induction of an
inflammatory response (Kerr et al. 1992). In
contrast, necrotic cells show extensive swelling,
distension of intracellular organelles, random
degradation of DNA, partial proteolysis and
permeabilization or rupture of membranes
(Syntichaki and Tavernarakis 2002).
Caspases are a family of intracellular cysteine-
type proteases, of which at least ten have been
characterized. They are involved in the
initiation and execution of the apoptotic
program. They exist in the cell as inactive
precursors, which are rapidly activated by
proteolytic cleavage in response to different
apoptogenic stimuli. Activation of key caspases
leads in a cascade-like fashion to specific
cleavage and activation of one or more of the
other caspases at their aspartic acid residue
(reviewed by (Salvesen and Dixit 1997)). Their
other proteolytic targets, of which nearly one
hundred have been identified, include essential
enzymes and structural components of the cell
such as nuclear lamins (Lazebnik et al. 1994,
Hengartner 2000). There are at least two well-
characterized caspase pathways that converge
at the activation of CASP-3 and ensuing
nuclear apoptosis, the indicators of which are
the cleavage of PARP and activation of  CAD
(caspase activated deoxyribonuclease) leading
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to fragmentation of DNA (Tewari et al. 1995,
Enari et al. 1998). The intrinsic pathway
involves mitochondrial release of apoptogenic
co-factors (see below) which in turn activate
CASP-9. The extrinsic pathway proceeds by
binding of a ligand to a membrane-bound
death receptor (Fas/TNF) leading to CASP-8
activation. In neurons, these two pathways
intertwine as NMDA-receptor-induced
apoptosis proceeds by increased Ca2+–loading
of the mitochondria causing their dysfunction,
generation of ROS, and subsequent CASP-9
activation (Krajewski et al. 1999). Production
of ROS has been implicated as a signaling
mechanism also in TNF-α-induced apoptosis
(Schulze-Osthoff et al. 1993, Goossens et al.
1995).
Neuronal apoptosis can be prevented either by
interfering with the upstream signaling for
caspase activation by antioxidants (e.g. N-
acetylcysteine) or antioxidative enzymes (SOD,
CAT), or by blocking the cascade by caspase
inhibitors  (e.g. CrmA, zVAD-fmk, Ac-
DEVD.CHO) (Ferrari et al. 1995, Greenlund
et al. 1995, Patel 1998). The ratio of activated
caspases to counteracting proteins may
determine, whether a cell will irreversibly enter
the death pathway after an apoptogenic signal
(Hengartner 2000). Some apoptotic pathways,
e.g. following exposure to irradiation,
peroxides, or chemotherapeutic drugs, are not
inhibited by caspase inhibitors (Kluck et al.
1997), indicating that caspases are not
necessarily involved in all forms of apoptotic
death. However, expression of CASP-3
appears to be a prerequisite at least for
developmental neuronal apoptosis, as CASP-3
deficient mice show marked cellular
hyperplasia restricted to the CNS (Kuida et al.
1996).
5.3 Mitochondrial control of
apoptosis
Many cell types undergoing apoptosis exhibit
an acute reduction of mitochondrial
transmembrane potential (∆Ψm), which is
considered to be the ‘point of no return’ of
apoptosis. This phenomenon, called the
permeability transition (PT), alters the
conductance of mitochondrial membrane by
sudden formation of pores at the inner and
outer membrane contact sites (Bernardi 1996).
Many factors influence the opening probability
of the PT pores, e.g. ROS, depletion or
oxidation of cellular GSH, sustained increase
of cytosolic and mitochondrial Ca2+
concentration, activation of caspases,
modification of the Bcl-2 complex and
membrane depolarization (Bernardi 1996,
Susin et al. 1996, Di Lisa and Bernardi 1998).
Opening of PT pores leads  to an efflux of
matrix Ca2+ and small (<1,5 kDa) molecules
(Zamzami et al. 1996) and compromises the
respiratory chain function, thus leading to
depletion of ATP, NAD(P)H, and GSH, and
to increased generation of O2.- (Marchetti et al.
1996). In some non-neuronal cell models,
these changes are associated with caspase
activation and nuclear degradation (Susin et al.
1996, Yang and Cortopassi 1998), but in
neurons caspase activation and subsequent
apoptosis can proceed independently of PT
(Budd and Nicholls 1996, Krohn et al. 1999).
It is also evident that, at least in neurons,
mitochondrial membrane depolarization, i.e.
loss of the proton gradient driving ATP
synthesis, can be a reversible event unrelated to
PT (Budd and Nicholls 1996).
One of the several mitochondrial factors
regulating apoptosis is cytochrome c (cyt c),
which can, by being released from the
mitochondrial intermembrane space, induce
CASP-3 cleavage and nuclear apoptosis in co-
operation with dATP and two cytosolic
proteins, apaf-1 and procaspase-9. These unite
to form an active pro-apoptotic complex
termed the apoptosome (Liu et al. 1996, Zou
et al. 1997). The release of cyt c may precede
PT (Kluck et al. 1997, Yang et al. 1997) but
can also follow it (Kantrow and Piantadosi
1997, Yang and Cortopassi 1998). PT itself
leads to the release of a ca. 50-kDa
intermembrane protein from a mitochondrium
to cytosol. This protein, referred to as
apoptosis-inducing factor (AIF), has been
shown to be sufficient by itself to cause CASP-
3 activation and nuclear apoptosis in vitro
(Susin et al. 1996). It is possible that these two
phenomena (release of cyt c and/or AIF) are
complementary pathways of apoptosis (Yang
21
et al. 1997). Recently it has been shown that
PARP-activation as such leads to translocation
of AIF from mitochondria to the nucleus
causing caspase-independent cell death (Yu et
al. 2002).
5.4 The Bcl-2 protein
The anti-apoptotic Bcl-2 protein is expressed
in the developing nervous system and is
associated with neuronal differentiation
(Hanada et al. 1993, Castren et al. 1994, Kim et
al. 1995, Zhang et al. 1996). It belongs to a
family that consists of several death-inducing
and -inhibitory members, which differ in their
expression patterns and in their structural
features (reviewed in (Kroemer 1997)). The
anti-apoptotic proteins of the Bcl-2 family
include Bcl-XL, Bcl-w, A1, and Mcl-1.
Proapoptotic members include Bax, Bik, Bak,
Bad, and Bcl-Xs (Yang and Korsmeyer 1996).
Many of the proteins of the Bcl-2 family, like
Bcl-2 itself, are located in the outer
mitochondrial membrane, which has been
considered essential to the anti-apoptotic
function (as well as to the proapoptotic
properties of Bax). However, the truncated
Bcl-2 protein lacking the membrane insertion
domain may retain some of its effects, possibly
by neutralizing other proapoptotic Bcl-2 family
proteins (Zhu et al. 1996). The members of the
Bcl-2 family are thought to competitively
homo- or heterodimerize forming an
equilibrium state between their pro- and anti-
apoptotic properties, and the outcome of a
stimulus depends on how it affects this balance
(Yang and Korsmeyer 1996).
Bcl-2 protein confers resistance against
apoptotic and, in some instances, necrotic
death in several neuronal models (Kane et al.
1993, Myers et al. 1995, Yang et al. 1997). For
instance, Bcl-2 overexpression protects neural
cells from death caused by pro-oxidants,
cyanide (Myers et al. 1995), Ca2+- ionophore,
withdrawal of serum,  growth factors or
glucose, (Zhong et al. 1993), and glutathione
depletion leading to generation of ROS (Kane
et al. 1993). Bcl-2 salvages cells from hypoxia-
induced death also in the absence of ROS
generation (Jacobson et al. 1993, Shimizu et al.
1995) and from apoptosis in the absence of a
nucleus (Jacobson et al. 1993). In Bcl-2
overexpressing 2-month-old mice, the size of
experimental cerebral infarction caused by
permanent ischemia is reduced by half
(Martinou et al. 1994), and the motor neurons
of these mice are protected from axotomy-
induced apoptosis (Farlie et al. 1995).
The early mitochondrial changes related to
apoptosis, such as the release of cyt c and the
PT, can effectively be inhibited by
overexpression of Bcl-2 or Bcl-XL (Susin et al.
1996, Yang et al. 1997, Shimizu et al. 1999).
The inhibitory effect of Bcl-2 can be bypassed
by ectopic cyt c (Kluck et al. 1997) or AIF
(Susin et al. 1996), suggesting that Bcl-2 and
related proteins may serve a gate-keeping
function in the mitochondrial membrane. The
three-dimensional structure of Bcl-XL has been
demonstrated to resemble the pore-forming
structures of bacterial toxins (Muchmore et al.
1996) and the protein is  inserted into lipid
bilayers forming cation-selective, ion-
conducting channels (Minn et al. 1997).
Whether or not this property of the Bcl-2
family is related to their ability to block PT or
apoptosis is yet unproven (Hengartner 2000).
The anti-apoptotic function(s) of Bcl-2 can be
inhibited by phosphorylation, e.g. through
activation of the JNK pathway (Thomas et al.
2000), or by cleavage by CASP-3 leading to the
release of a pro-apoptotic fragment of Bcl-2
(Kirsch et al. 1999).
6 OVERVIEW OF EXPERIMENTAL
ASPHYXIA MODELS
Although the association of transient global
hypoxia-ischemia, excitotoxicity, and
inflammation with ensuing cell damage has
been extensively characterized, we are still
lacking an experimental model that can
unequivocally reproduce the specific cerebral
lesions and delayed energy depletion caused by
perinatal asphyxia in the developing human
CNS. Inter-species variation in gestational
development and cerebral topography preclude
direct extrapolations, but several animal
models have been characterized to simulate
perinatal asphyxia and to test preventive
methods. All of the currently used methods
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have certain limitations, but depending on the
end-point under investigation and the
methodology used, they add useful
information on the field of ischemia-
reperfusion research.
The delayed energy failure recorded in human
infants asphyxia (Azzopardi et al. 1989, Wyatt
1993) is most accurately reproduced in a
newborn piglet model, in which transient
bilateral common carotid artery occlusion is
combined with reduction of the inhaled O2
content (Lorek et al. 1994). This method,
however, rules out reactive hyperperfusion
both upon initiation of HI and at the
reperfusion phase, which have been
characterized in a piglet model using transient
hypoxia without carotid occlusion (Ioroi et al.
2002). Nevertheless, this is a widely accepted
model for assessing potential rescue therapies
(Pourcyrous et al. 1993, Peeters-Scholte et al.
2002, Peeters-Scholte et al. 2003). Formation
of free radicals in the reperfusion phase after
transient complete ischemia has been
demonstrated in a neonatal piglet (Pourcyrous
et al. 1990) and in a neonatal sheep model
simulating asphyxia by transient ligation of the
communicating vertebral arteries in addition to
the carotid blood supply (Bågenholm et al.
1998). Periventricular white matter lesions,
similar to human PVL, can be induced by
hemorrhagic hypotension in fetal sheep
(Kusaka et al. 2002). Studies using repeated or
prolonged umbilical cord compression in
sheep have demonstrated ensuing
periventricular and cortical lesions but also
delayed periventricular necrosis accompanied
by microglial activation (reviewed in (Rezaie
and Dean 2002)). The Rice-Vannucci model is
a widely used classical immature rodent
ischemia model, which employs unilateral
carotid occlusion of one-week old postnatal
rats (Vannucci and Vannucci 1997), although it
is more representative of stroke than of
asphyxia.
Animal models, by allowing clinical and
histopathological evaluation, aid in depicting
the time sequence of pathophysiological events
and their relationships and are, of course, the
only method to validate potential therapeutic
means before clinical trials in human infants.
The inter-species differences, however, are well
reflected in the lack of efficacy in preventing
human HIE of numerous compounds that
have shown promise in animal studies. To
understand and benefit from the findings on
laborious experimental animal models,  parallel
investigation of  intracellular events and
intercellular interactions using complementary
in vitro methods is imperative.
Organotypic culture is an approach in between
the in vivo models and cell culture systems
devoid of physiological interactions. It takes
advantage of the preservation of functional
synapses and structural properties of the CNS.
Slices of (most commonly) rat hippocampal
tissue are cultured on semiporous membrane
and can be exposed in growth medium to
conditions that mimic ischemia (Vornov and
Coyle 1991). Furthermore, the organotypic
cultures allow for transgenic expression by
viral transduction (Ehrengruber et al. 1999).
They have also been established from human
brain tissue obtained at epilepsy surgery or
from post-mortem cortical preparations of
elderly subjects (Verwer et al. 2002).
The lack of ability of neurons to divide after
differentiation sets limitations to their use in
culture. The most widely used neuronal cell
systems employ primary cultures, i.e. culture of
neurons dissected from a specific area of
embryonic brain as mature neurons have
decreased survival potential. The cells are
planted on culture dishes, usually under
conditions that do not allow proliferation of
non-neuronal dividing cells, to achieve a
homogenous population of neurons. The
purity of a given neuronal population varies
according to the methods of preparation,
culture conditions and length of the culture
period.
Preparation of human embryonal neurons for
primary culture from samples obtained at
elective abortions is possible, but ethical
constraints and relatively few advantages over
animal cultures limit their usage. The most
commonly used neuronal culture systems in
the field of cerebral ischemia are rodent
primary cultures using cortical or hippocampal
neurons. Cells derived from the peripheral
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nervous system are more rarely used in CNS
ischemia-reperfusion
settings. Cell culture permits the use of
multiple and reproducible approaches to
simulate ischemia/reperfusion, and to control
and monitor enzyme function, gene
expression, and the extra- and intracellular
compartments. However, as previously
mentioned, their physiological interactions are
lost, and therefore results obtained in a cell
model must be interpreted with caution. To
overcome the problems of inter-species
variation in interpreting results, several cell
lines of human origin with a neuron-like
phenotype have been used. A human cortical
cell line, HCN-1A, was established from a
patient with a disorder associated with
continued proliferation of immature neuronal
cells. The HCN-1A line can be induced to
differentiate in vitro to express mature neuronal
morphology and markers (Ronnett et al. 1990).
The use of HCN-1A in cerebral ischemia
investigation, however, has been limited. Other
examples of continuous neuron-like human
cell lines are the neural crest derived cell line
Paju, (Zhang et al. 1996),  the neuroblastoma
line SY5Y (David et al. 1997), and the
teratocarcinoma-derived NT2-N cells (Pleasure
et al. 1992).
The most simplified line of study takes
advantages of the ubiquitous basal cellular
functions in mammalian cells. In cell free
systems, control of confounding factors is
thought to be maximized as only selected
cellular organelles are isolated and investigated.
Many advances in e.g. apoptosis research are
achieved by using subcellular fractions or cell-
free extracts (see section on mitochondrial
control of apoptosis).
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7 CLINICAL STRATEGIES FOR
NEUROPROTECTION
The newborn brain is particularly vulnerable to
ischemia/reperfusion damage due to its limited
antioxidative capacity (Hamrick and Ferriero
2003). Moreover, the concentration of free
iron is rather high adding to increased
vulnerability to and generation of ROS (Palmer
et al. 1999), and circulating levels of GSH and
transferrin are relatively low (Vannucci and
Perlman 1997). Feasible approaches to modify
or prevent delayed neuronal death are listed in
table 2  (modified from (Hamrick and Ferriero
2003)).
Table 2. Approaches to alleviate or prevent
ischemia-induced neuronal death.
Reduction of ROS formation
Preservation of energy metabolism
Inhibition of neuronal membrane depolarization
and release of glutamate
Blockade of glutamate-sensitive NMDA-receptors
Prevention of Ca2+-overload
Modulation of inflammation
Inhibition of PARP activation
Interference with apoptotic pathways (caspase
activation, PT)
Until now, pharmaceutical intervention ideas
have been tested in animal asphyxia models
and have focused on ROS scavengers,
glutamate-receptor antagonists, calcium
antagonists, growth factors, cytokine
modulators, along with inhibitors of the
NOS’s and caspases. Most of these
compounds, unfortunately, have shown benefit
only when given before birth (Berger and
Garnier 1999), and none of them has yet
proven effective in clinical practice.
In the developing brain,  NMDA-antagonists
(eg. MK-801) may be neurotoxic (Ikonomidou
et al. 1999), although immature rat models
have showed substantial neuroprotection
(Vannucci and Perlman 1997). A randomized,
prospective clinical study on severely
asphyxiated infants given a single high-dose of
the general anticonvulsant phenobarbital after
birth, however, was associated with a 27%
reduction in the incidence of seizures and a
significant improvement in neurologic
outcome at 3 years of age (Hall et al. 1998).
Probably the most promising line of treatment
is selective hypothermia (Berger and Garnier
1999), which is effective still at 6 h after
asphyxia. Hypothermia may act via several
mechanisms listed above (Taylor et al. 2002,
Hamrick and Ferriero 2003), and clinical trials
on human infants are currently ongoing
(Whitelaw and Thoresen 2002).  In a recent
large multi-center clinical study, reduction of
cerebral palsy and mortality by 17% was
achieved by treating mothers with threatened
delivery with magnesium sulfate, which acts by
blocking the NMDA-receptors. Neonatal
morbidity was not reduced, but no adverse
effects of magnesium were recorded in this
material (Crowther et al. 2003).
As some of the inhibitors of ROS-generating
enzymes have been used without side effects
for other indications, they have been subjected
to extensive study in asphyxia models. The
importance of antioxiant defece is shown, for
example, by the considerable alleviation of
cerebral reperfusion injury in mature mice
overexpressing CuZnSOD (Yang et al. 1994,
Chan et al. 1998). The extent of the
reperfusion-related neuronal damage in animal
models has been shown to be decreased by
inhibition of ROS-generating enzymes, e.g.
cyclo-oxygenase by indomethacin (Armstead et
al. 1988, Pourcyrous et al. 1993), and XOR by
oxy- or allopurinol (Phillis and Sen 1993). In a
small material consisting of 22 newborn
infants, treatment by allopurinol was
promisingly shown to decrease plasma pro-
oxidant activity and preserve postasphyxial
cerebral blood flow and electrical brain activity
with no side-effects (Van Bel et al. 1998).
Prevention of NOS induction by 2-
iminobiotin, a selective iNOS and nNOS
inhibitor, offered substantial neuroprotection
and preserved neuronal energy status in piglets
when given as intravenous treatment after
asphyxia (Peeters-Scholte et al. 2002). In
contrast, inhibiting the vasodilatatory eNOS by
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using non-selective inhibitors may enhance
neurotoxicity (Kamii et al. 1996).
PARP-deficient mice are virtually resistant to
neuronal and myocardial ischemia (Eliasson et
al. 1997, Endres et al. 1997), hemorrhagic
shock (Liaudet et al. 2000), and experimental
diabetes (Masutani et al. 1999). Therefore,
methods directed towards inhibition of excess
PARP activation have also been tested in
animal models of asphyxia. Although it has
been suggested that inhibition of PARP either
by gene deletion or by pharmacological means
confers protection only against necrosis but
not apoptosis (Ha and Snyder 1999, Moroni et
al. 2001), in vivo inhibition of PARP by mimics
of the end-product nicotinamide is protective
even as post-treatment of experimental stroke
(Endres et al. 1997, Takahashi et al. 1997,
Takahashi et al. 1999). Inhibiting caspases by a
pan-caspase inhibitor is also partially protective
in an animal asphyxia model (Cheng et al.
1998).
Because hypoglycemia often complicates
asphyxia also in non-diabetic pregnancies
(Dalgic et al. 2002), asphyxiated neonates are
commonly treated with excess glucose.
Hypoglycemia itself enhances excitotoxicity
(Wieloch 1985, Ichord et al. 2001). Post-
asphyxial hyperglycemia, however, does not
improve recovery in vivo (Sheldon et al. 1992),
and may in contrast aggravate neuronal ROS
production and increase apoptosis (Russell et
al. 2002). However, in immature CNS the
inverse effects of excess glucose are not as
unequivocal as those seen following adult
stroke. This may be explained by the limited
capacity of immature glucose transporters and
possibly by the enhancement of intracellular
glycolytic flux (Vannucci and Perlman 1997).
As ketone bodies and citric acid cycle
intermediates can be used by neuronal cells as
an alternative energy source (Massieu et al.
2003, Tieu et al. 2003), and as the brain uptake
is increased proportionally to their blood
concentration (Hawkins et al. 1971), they could
be envisaged to be a component of the post-
asphyxic rescue treatment. However, clinical
studies on their neuroprotective effect have
not been reported.
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AIMS OF THE STUDY
This series of studies using cultured neuronal cells is aimed at investigating the mechanisms
and consequences of an oxidant-induced neuronal injury with an emphasis on cellular energy
metabolism. It was hypothesized that the biphasic energy disturbance associated with
delayed neuronal damage in the newborn animal could be reproducible in a cultured cell
model and can be utilized for mechanistic and therapeutic studies.
The specific aims were to study:
-whether the severity of an acute high-energy nucleotide depletion caused by a transient
oxidative insult correlates with the nature and degree of the ensuing cell injury in a human
neural crest-derived cell line, and whether the levels of cellular Bcl-2 expression correlate
with vulnerability to oxidative insults (I)
-whether an acute disturbance in the amount and balance of high-energy nucleotides caused
by a transient oxidative insult in a model of cultured rat embryonal cortical neurons is
reversible and whether its severity predicts later ATP synthesis and subsequent mode of cell
death (II)
-whether modification of the extent of ATP depletion during an acute oxidative insult by a
specific inhibitor of PARP influences the fate of the cells and the cleavage of PARP itself (III)
-whether altering the levels of extracellular glucose or the rate of glycolysis, with or without
an acute oxidative insult, modulate the effects on energy metabolism and cellular outcome,
and whether post-insult addition of citric acid cycle intermediates promotes recovery from
an oxidative insult combined with hypoglycemia (IV)
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MATERIALS AND METHODS
8 OVERVIEW OF METHODS FOR
STUDYING CELLULAR EFFECTS OF
ROS
8.1 Exogenous oxidants
Exposure of cells to exogenous H2O2 is a
widely used approach to simulate oxidative
stress  (for a review, see (Burdon 1995)) as
H2O2 freely crosses cell membranes. To study
the effects of  O2.- , cell cultures can be treated
with the combination of exogenous XOR and
its substrate hypoxanthine (Kuppusamy and
Zweier 1989). Quinones, e.g. menadione, are
capable of being reduced by mitochondrial
enzymes to semiquinones, which in turn can
produce O2.- and H2O2 by continuous redox-
cycle reactions. Furthermore, quinones and
semiquinones can react with the -SH groups of
cellular proteins, as well as GSH (Halliwell and
Gutteridge 1989). Mitochondrial
overproduction of ROS can be induced by
inhibition of mitochondrial respiratory
complexes III (by e.g. antimycin-A) or IV (by
e.g. potassium cyanide), while mitochondrial
production of ROS can be inhibited by
blocking the electron flow to ubiquinone by
respiratory complex I inhibitors (e.g. rotenone)
(Nicholls and Budd 2000).
8.2 Adenine nucleotide depletion
assay
Exposure of cultured cells to ROS can induce
adenine nucleotide depletion and membrane
damage (Aalto and Raivio 1993). Nucleotides
can be measured in cell extracts, and the
adenylate energy charge, EC, calculated from
the relative concentrations of adenine
nucleotides (([ATP] + ½ [ADP]) / ([ATP] +
[ADP] + [AMP]); where brackets denote
concentration), has been used as a parameter
of the metabolic integrity of the cell (Atkinson
1968). An alternative approach to investigate
intracellular adenine nucleotide metabolism is
prelabeling of cultured cells with 14C-adenine.
After the exposure of the cells to ROS, the
adenine nucleotides (ATP, ADP, AMP) and
their catabolic products (hypoxanthine,
xanthine and uric acid) can be extracted and
quantified separately in the cells and media by
thin layer chromatography (Aalto and Raivio
1990). Since nucleotides do not cross intact cell
membranes, whereas purine nucleosides and
bases do (Plagemann et al. 1988), detecting
intact nucleotides in the medium implies
membrane damage (Ager and Gordon 1984).
Impairment of the adenine nucleotide
metabolism is a very sensitive indicator of early
cell injury, metabolic changes, and sublethal
damage (Ager and Gordon 1984, Andreoli
1989).
Figure 5: Method of prelabeling the cells with 14C-adenine.
The 14C-labeled adenine added to the culture medium is
actively taken up by the cells. Adenine
phosphoribosyltransferase catalyzes the formation of AMP
from phosphoribosyl pyrophosphate (PRPP) and adenine. By
interconversion, the high-energy nucleotides are labeled in
proportion to the total adenylate pool. The ratio of the
radioactivities of different high-energy nucleotides at a given
time reflects the metabolic status of the cell. The
radioactivities of the catabolic products (Hx, hypoxanthine; X,
xanthine; UA, uric acid), as well as of nucleotides leaked out
of the cell,  can be measured in the medium.
28
8.3 Detection of the mode of cell
death
Definition of apoptosis in cell systems or
histological preparations is considered to
require the demonstration of at least two of its
morphological or biochemical hallmarks
(Lemasters 1999). Evidence of the typical
apoptotic morphologic characteristics, such as
blebbing of the cell membrane (zeiosis) and
cytosolic shrinking, by light or electron
microscopy is considered an irrefutable
method. Visualization of the nuclear events,
including condensation of chromatin,
pyknosis, and subsequent DNA degradation, is
feasible using chromatin-binding fluorescent
dyes. In addition, there are a number of
complementary methods, such as detection of
the degradation of DNA to 185 bp fragments
in gel electrophoresis as a typical ‘ladder’. For
in situ detection of apoptotic cells,
immunohistochemical or fluorescent 3’-end-
labeling of DNA-fragments can be used. Other
methods include flow cytometry, in which
apoptotic cells can be demonstrated and
quantified by their reduction in size and DNA
content (reviewed in (Willingham 1999)).
During necrosis DNA degradation is random,
which in DNA electrophoresis typically yields
a ‘smear’ pattern. In some cell systems, the
externalization of phosphatidylserine residues,
a hallmark of apoptotic changes of the cell
surface, can be demonstrated by binding of
fluorescently labeled annexin V on the cells
(Willingham 1999).
9 METHODS USED IN THE CURRENT
SERIES OF STUDIES
9.1 Cell culture
9.1.1 Paju cells
Paju is a primitive neuroectodermal tumor cell
line growing NGF-independently adherent to
surface. Paju cells exhibit spontaneous neural
differentiation in culture, and constitutively
express neuron specific enolase (NSE) and
Bcl-2 protein. Their  differentiation can be
induced further by phorbol 12-myristate 13-
acetate (PMA) or by Bcl-2 overexpression
(Zhang et al. 1996). In this study, two Paju cell
lines (a gift from Prof. Leif Andersson,
Department of Pathology, University of
Helsinki, Helsinki) were used:  The wild type
(WT) line and a line stably overexpressing the
human Bcl-2 protein (BCL-2). The cells were
cultured in RPMI 1640 medium (Gibco
Europe, Paisley, U. K.) supplemented with
10% fetal bovine serum (Gibco). The medium
for the BCL-2 was supplemented with 500 µM
G-418 (Geneticin, Sigma Chem., St. Louis,
MO, USA). The stable overexpression of Bcl-2
protein was confirmed regularly by culturing
the BCL-2 line in serum-free medium. As
previously described, Bcl-2 overexpression
enables the cells to survive and differentiate
under the conditions which do not support the
growth of WT cells (Zhang et al. 1996). These
lines were tested and found negative for
mycoplasma contamination.
9.1.2 Rat embryonal cortical neurons
Primary cell cultures from cerebral
hemispheres of 18-day-old rat embryos,
referred to in the text as rat cortical neurons,
were prepared according to the method
described by Rauvala et al (Rauvala et al. 1988).
The lenght of gestation was counted from the
day of separation of the male and female (E0).
Freshly prepared neurons in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco
Europe, Paisley, U. K.), supplemented with
10% fetal bovine serum and containing 6 g/l
glucose and penicillin/streptomycin (100
IU/ml and 50 µg/ml), were plated on poly-L-
lysine-coated four-well culture dishes (Nunc,
Roskilde, Denmark) or 50 mm petri dishes
(Nunc) at a controlled density averaging 750–
1000 cells/mm2, and cultured in 95% air/5 %
CO2 at 37°C in a humidified incubator. To
prevent the proliferation of non-neuronal cells,
the culture medium was changed to serum-free
Neurobasal-medium supplemented with
B27 (Gibco) and 0.5 mM glutamine on day 1,
and replaced after three days. These cells have
been shown to be mainly (80-90%) neurons
(Rauvala et al. 1988). This primary cell culture
system was approved by the animal subjects
review board of the University of Helsinki.
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9.2 Oxidant exposure
The H2O2 exposures on Paju cells were started
using cell cultures in four-well dishes (Nunc) at
a controlled density averaging 1000 cells/mm2.
The medium was replaced with serum-free
RPMI and H2O2 was added to a final
concentration of 0 µM, 10 µM, 50 µM,100 µM,
250 µM, 5 mM, or 10 mM H2O2 (Merck AG,
Darmstadt, Germany). The cortical neurons
were exposed to H2O2 on day 5 to 7 after
plating, when the cells were showing marked
neuronal outgrowth. The medium was replaced
with serum-free DMEM containing freshly
prepared H2O2 at a final concentration of  10
µM, 50 µM, 100 µM, 200 µM, 250 µM, 1 mM,
or 5 mM and incubated at 37°C for 60 min.
After exposure, the cells were either
immediately analyzed, or the exposure medium
was replaced by regular culture medium, the
cells were further incubated for 24 h, 48 h, or
72 h, and then analyzed. The H2O2
concentrations were verified by
spectrophotometric analysis at 240 nm, using
the molar extinction coefficient of 44 M-1 cm -1
for H2O2. Control cells were treated similarly
but with omission of H2O2.
9.3 Treatment with DPQ,
α−ketoglutarate, or pyruvate
To study the modification of oxidant toxicity
by 3,4-Dihydro-5-[4-(1-piperidinyl)butoxy]-
1(2H)-isoquinolinone (DPQ) (Alexis
Corporation, San Diego, CA), a specific PARP
inhibitor, rat cortical neurons were exposed to
freshly prepared H2O2 in serum-free DMEM
with or without 30 µM  DPQ. To test the
effects of  α-ketoglutarate or sodium pyruvate
after an oxidative insult, the H2O2-containing
medium was replaced after exposure by
defined culture medium (Neurobasal + B27,
containing 25 mM glucose and 0.5 mM
glutamine) with or without 5 mM
α−ketoglutarate (Sigma Chemical Co., St.
Louis, MO., USA) or 5 mM sodium pyruvate
(Sigma).
9.4 Nucleotide depletion assay
Before oxidant exposure,  Paju cells were
prelabeled for 6 h and cortical neurons for 12
h with 14C-adenine (final concentration 100
µM, specific activity 51-55 mCi/mmol,
Amersham Int., Amersham, U. K.) in normal
culture medium. The labeled medium was then
removed, the cells were washed, and exposed
as appropriate. Directly after exposure, the
medium was removed, cellular adenine
nucleotides (ATP, ADP, AMP) were extracted
on ice with perchloric acid and quantified by
using thin layer chromatography (Aalto and
Raivio 1990). Radioactivities were measured
with a liquid scintillation counter (Rackbeta
1209, LKB Wallac, Turku, Finland). The
adenylate energy charge, EC, was calculated
from the radioactivities in the adenine
nucleotides, which correspond to their
intracellular concentrations (Aalto and Raivio
1993).
9.5 Analysis of adenine nucleotides
by HPLC
ATP, ADP, and AMP concentrations in
neutralized perchloric acid extracts were
measured using a Shimadzu LC 10AD vp
liquid chromatograph with a reversed phase
column (Ultra Techsphere 5 ODS, Labtronic
Oy, Vantaa, Finland) and an UV detector set at
254 nm. The method by (Stocchi et al. 1987)
was modified as follows: Buffer A (0.1 M
KH2PO4, 8.0 mM tetrabutylammonium
hydrogen sulfate, pH 6.0) was run at 1.5
ml/min for 2.5 min followed by a linear
increase over 10 min to 100 % Buffer B
(buffer A with 30 % methanol), which was
continued for 5 min. Compounds were
identified and quantified by the retention times
and peak areas of known standards, calibrated
by spectrophotometry. The adenine nucleotide
concentrations were normalized to cellular
protein concentration.
9.6 Post-exposure adenine
nucleotide synthesis
To measure the capacity to  incorporate 14C-
adenine into cellular nucleotides after an
oxidant exposure, the fresh culture medium of
exposed as well as unexposed control cultures
was supplemented with 14C-adenine (final
concentration 100 µM). After further
incubation for 24 h, the cellular adenine
30
nucleotides were extracted with perchloric acid
on ice and quantified as described.
9.7 Detection and  quantification of
apoptosis
9.7.1 Analysis of DNA-degradation
Two methods to assess the molecular size of
DNA fragments in oxidant-treated and control
cells were used. Firstly (I), DNA from the
exposed cells was extracted with phenol-
chloroform, end-labeled with digoxigenin-11-
ddUTP (DIG-ddUTP, Roche Biochemicals,
Basel, Switzerland), electrophoresed (50 V, 3.5
h) on 2 % standard low-melting agarose gel
and blotted onto a nylon membrane overnight.
The bound DNA was located by an alkaline
phosphatase conjugated anti-digoxigenin
antibody (Anti-Digoxigenin-AP, Roche, 1: 10
000) followed by chemiluminescence reaction
(CSPD, Roche). Paju WT cells treated for 30
min by potassium cyanide and deoxyglucose to
induce apoptosis in 12 h (our unpublished
results) were used as a positive control for
DNA fragmentation.
For the second method of DNA analysis (II,
III), the exposed cells as well as their
unexposed controls were quickly frozen in
liquid nitrogen. DNA was extracted using the
Apoptotic DNA ladder kit (Roche), quantified,
and electrophoresed (3 µg/lane, 50 V, 3.5 h)
on standard agarose gel, visualized with a
fluorescent DNA-binding dye SYBR Gold
(Molecular Probes Europe BV, Leiden, The
Netherlands), and photographed under UV-
illumination.
9.7.2 Assessment of nuclear morphology
Aliquots of the exposed Paju cells were fixed
in 4% phosphate-buffered formaldehyde,
stained overnight with the fluorescent DNA-
binding probe Hoechst 33348 (Molecular
Probes) at a concentration of 0.4 mg/ml,
resuspended in 50% glycerol in PBS, and
visualized under fluorescent microscopy using
a UV-A filter with an excitation wavelength of
340 to 380 nm (Leica, Germany). The cortical
neurons were fixed in 4% paraformaldehyde
and, after washing, stained with the probe
Hoechst 33348 (Molecular Probes) at 15
µg/ml in room temperature for 20 min, and
visualized under fluorescent microscopy. The
cells were also photographed under a light
microscope (200X, interference contrast).
9.7.3 In Situ End-labeling of DNA (ISEL)
The rat cortical neurons were plated on poly-
L-lysine-coated round glass coverslips on four-
well culture dishes (Nunc) and grown as
described earlier. After exposure to indicated
concentrations of H2O2 for 60 min, they were
incubated in the regular culture medium for 24
h, washed twice, and fixed in 4%
paraformaldehyde. The cells were
permeabilized in ice-cold mixture of ethanol
and acetic acid (2:1) and, after washing, in a
microwave oven for 5 min in 10 mM citric acid
(pH 6.0). After washing, the cells were
preincubated with terminal transferase reaction
buffer (potassium cacodylate 1 mol/L, Tris-
HCl 125 mmol/L, bovine serum albumin 1.25
mg/ml, pH 6.6). The apoptotic DNA
fragments were 3’ -end-labeled with DIG-
ddUTP (Roche Diagnostics, Mannheim,
Germany) by the terminal transferase (TdT,
Roche Diagnostics) reaction for 1 h at 37°C.
Antidigoxigenin antibody conjugated to
horseradish peroxidase (1:50, Roche
Diagnostics) and diaminobenzidine (Sigma)
were used to detect DIG-ddUTP-labeled
DNA. For the negative controls, the TdT
enzyme was replaced by the same volume of
distilled water. The coverslips were then
dehydrated, mounted, and photographed
under a light microscope (400X, interference
contrast).
9.8 Western blotting of PARP
Rat cortical neurons were cultured on 50 mm
petri dishes and exposed to H2O2 with or
without DPQ as indicated. After 24 h, the cells
were scraped into sterile ice-cold PBS,
centrifuged, and resuspended in reducing
loading buffer (62.5 mM Tris, pH 6.8, 6 M
urea, 10% glycerol, 2% sodium dodecyl
sulphate, 0.003% bromophenol blue, and 5%
2-mercaptoethanol). The cells were sonicated
on ice and stored at –20°C. For western
blotting, the samples were incubated for 15
min at 65°C, 20 µg of protein per sample were
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loaded and separated by SDS–PAGE
electrophoresis, and transferred onto a
nitrocellulose membrane. Membranes were
probed with a monoclonal anti-PARP-
antibody (No. C2.10, Enzyme Systems
Products, Livermore, CA, USA) at a dilution
of 1:10000 followed by enhanced
chemiluminescence detection (Amersham,
Buckinghamshire, UK).
9.9 Protein analysis
Cells from parallel co-cultures were
homogenized in K-phosphate buffer, and
their protein content was determined by
spectrophotometry using the Bio-Rad DC kit
(Bio-Rad, Hercules, CA, USA).
9.10 Cell counts
The number of cells was determined by
counting the nucleus-containing cells from
three randomly selected fields per condition
from three separate experiments at 24 h
following appropriate exposures.
9.11 Data analysis
Results are expressed as means ± SD of 4-12
parallel independent experiments performed
at least in duplicate, each with its own
control. The statistical group comparisons
were made between control and test
conditions by the non-parametric Kruskall-
Wallis ANOVA combined with Bonferroni
correction, or using the non-parametric
Mann-Whitney U-test (SPSS 7.5 software for
Windows, SPSS, Chicago, IL, USA).) The
association between EC and adenine
nucleotide concentrations and cell viability
was assessed by Pearson correlation analysis
after logarithmic transformation of the values.
Statistical significance is assumed at p<0.05,
and in experiments on PARP inhibition, at
p<0.01. For illustration, the data are also
shown as per cent of control.
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RESULTS
10 OXIDANT EFFECTS ON HUMAN
NEURAL CREST-DERIVED CELLS (I)
10.1 Nucleotide depletion
When cultured human neural crest-derived
tumor cells were exposed to H2O2 for 60 min,
the adenine nucleotides of both WT and BCL-
2 lines were depleted. In WT cells this was
dose-dependent, from no effect at 100 µM
H2O2, ranging to maximal depletion at 10 mM
exposure. The adenine nucleotides of BCL-2
cells were maximally depleted already at 250
µM H2O2, with no further effect at 5 mM or
10 mM H2O2 exposures (Figs. 6A and 6B).
The EC of WT cells decreased dose-
dependently only at concentrations exceeding
250 µM, which in BCL-2 cells already caused a
significant decline (Fig. 6B).
10.2 Cell and DNA damage
The lowest exposure (100 µM) to H2O2 did
not affect the growth properties of either cell
line, which were comparable when followed
for 48 h. A 60-min exposure to 250 µM H2O2
inhibited proliferation of both cell lines during
the follow-up but did not increase cell death.
When the exposure was intensified to 5 mM
H2O2, the surviving cell counts at 24 h were
43±17% and 28±21% of unexposed control
cultures in WT and BCL-2 cells, respectively
(n.s. between cell lines, p = 0.05 vs. cell counts
at 60 min and vs. untreated control cultures).
In WT cells the decline in viability progressed
to 72 h (10+5%), and there was a significant
difference (p = 0.05) in the number of viable
cells between 48 h and 72 h, whereas the
counts of BCL-2 cells did not change between
24 h and 72 h (not shown). After 10 mM
H2O2, there were no surviving cells of either
cell lines at 24h. (I, Fig. 3).
DNA electrophoresis of WT cells showed
fragmentation indicative of apoptosis when
studied 12 h after a 60-min exposure to 5 mM
H2O2, whereas the DNA of BCL-2 cells
showed a uniform smear. After 24 h and 48 h,
in both cell lines non-specific DNA
fragmentation was observed. When the nuclear
morphology of H2O2-exposed cells was
followed for 48 h, the nuclei of WT cells
exposed to 5 mM H2O2 for 60 min became
shrunken, but condensation of chromatin
typical of apoptosis was not detected. In BCL-
2 cells, a 60-min exposure to 5 mM H2O2 was
followed by nuclear enlargement and
fragmentation after 24 h, and these changes
progressed by 48 h. No morphological features
of apoptosis were observed (I, Figs. 5 and 6).
Fig. 6. (A) Cellular adenine nucleotides and (B) Cellular EC at the end of a 60-min exposure to indicated concentrations of
H2O2:         control;        50 µM;       5 mM;      10 mM, **p <  0.01. (C) Correlation of EC at the end of a 60-
min exposure to H2O2 with cell viability at 24 h in WT (solid line) and BCL-2 (dashed line) cells. Data are expressed as %
of control cpm (adenine nucleotides) and absolute values (EC). *p  < 0.05, **p < 0.01, ***p < 0.001 (Mann Whitney U-
test).
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10.3 Correlation of EC with further
growth
The EC at the end of 60 min of H2O2
exposure correlated well (r2 = 0.99, p < .01 and
r2 = 0.99, p = < .05, for WT and BCL-2 cells,
respectively) with viable cell counts at 24 h
(Fig. 6C and I, Figs. 4 A and B). The
correlation of the initial adenine nucleotide
depletion with viability at 24 h was strong in
WT cells (r2 = 0.99, p < .05), but non-
significant in BCL-2 cells (r2 = 0.32).
11 OXIDANT EFFECTS ON
CULTURED CORTICAL NEURONS (II)
11.1 Nucleotide metabolism
In rat cortical neurons, exposure to H2O2 for
60 min caused an acute dose-dependent
reduction in total cellular adenine nucleotides,
which was accompanied by a corresponding
increase in catabolic products in the culture
medium, most of the radioactivity being in
hypoxanthine. Reduction in cellular ATP
after a 60-min exposure to H2O2 was more
pronounced than that of total adenine
nucleotides at intermediate to high
concentrations, reflecting a corresponding
decrease in cellular EC. Increasing H2O2
concentration to 5 mM caused a total
depletion of cellular ATP (II, Fig. 3).
Adenine nucleotide metabolism in neurons
after transient H2O2 exposure was studied by
following 14C-adenine incorporation into
ATP and by measuring ATP levels by HPLC.
Both methods indicated a dose-dependent
pattern. Low concentration of H2O2 (10–50
µM) caused no significant changes relative to
control cells, but in cells exposed to 100 µM
H2O2, which caused significant acute ATP
depletion, the radioactivity in ATP recovered
to control values at 12 h but showed a
secondary decline at 24 h. After exposure to 1
mM H2O2, there was no recovery of ATP
synthesis from 14C-adenine (II, Fig. 4).
Radioactivity in ATP was in normal
equilibrium with the other high-energy
nucleotides, so that the cellular EC levels
were at control levels (0.92 + 0.02) during the
follow-up period at all exposure levels. The
ATP concentrations measured by HPLC,
normalized to protein content, corresponded
well with the incorporation of 14C-adenine
into cellular high-energy nucleotides (II, Fig.
5). The ATP concentration of cells exposed
to 1 mM H2O2 was under the detection limit
for the HPLC method at all time points
investigated.
Both at the end of the 60-min exposure, and
after 24 h of subsequent incubation,
radioactivity in nucleotides recovered from
the medium remained at control values at all
exposure levels. This indicates that the
nucleotide depletion was the result of
intracellular catabolism and not leakage from
damaged cells.
11.2 Cell and DNA damage
When examined after 24 h, rat cortical neurons
exposed for 60 min to 10-50 µM of H2O2 did
not differ morphologically from control cells,
whereas cells exposed to 100 µM H2O2 were
round, pyknotic, and showed uniform in situ 3’-
end labeling. Cells exposed to a higher
concentration of H2O2 (1mM) formed a
necrotic mass with distorted cell outlines at 24
h, but ISEL showed a scarce pattern of nuclear
staining (II, Fig. 1).
The yields of extracted DNA at 24 h from
plates exposed to 100 µM and 1 mM H2O2 for
60 min were significantly lower than those
from unexposed control cells, indicating a
corresponding loss of cells. The yield of
extracted DNA and DNA electrophoresis
pattern of cells exposed to 10 µM-50 µM
H2O2 at 24 h did not differ statistically from
that of the unexposed control cells (II, Fig. 2,
lane 1 and 2).
After exposure to the intermediate
concentration of H2O2 (100 µM), the extracted
DNA was visualized after electrophoresis as a
‘ladder’ pattern suggestive of apoptosis (II, Fig.
2, lane 3). Exposure to higher (1 mM to 5 mM)
concentrations of H2O2 resulted in DNA
‘smear’ (II, Fig 2, lane 4). However,
occasionally a ladder of DNA was detected
also in these cells (II, Fig 2, lane 5). This
possibly represented fragmented DNA of
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residual apoptotic cells, whereas the completely
degraded DNA of necrotic cells would not be
detected in electrophoresis nor in DNA assay.
12 PREVENTION OF OXIDANT
DAMAGE BY PARP-INHIBITION (III)
12.1 Nucleotide depletion
The effects of inhibition of PARP using the
specific inhibitor DPQ, on varying degrees of
acute oxidative insult were assessed in neurons
subjected to ‘mild’ (50 µM), ‘moderate’ (100-
250 µM), or ‘severe’ (500 µM–1 mM) H2O2
exposure resulting in progressively more severe
acute ATP depletion. When the cells were
exposed to H2O2 for 60 min in the presence of
30 µM DPQ, the acute depletion of ATP and
ANs in the ‘moderate’ group were alleviated to
the ‘mild’ level. In the ‘severe’ group, there was
partial recovery of ATP levels, and also the
decrease of the EC was significantly reduced
by DPQ-treatment (III, Fig. 1).
12.2 Delayed effects
When DPQ was present during the H2O2
exposure, ATP synthesis from 14C-adenine,
normalized to cell counts, was not significantly
improved in cells when compared to those
exposed to H2O2 alone (III, Fig. 4). However,
treatment with DPQ caused a significant
recovery of the number of cells after severe
exposure, also when applied only post–insult
(p. i.) (III, Fig. 2).
Treatment of the cells with DPQ during
moderate and severe H2O2–exposures resulted
in marked preservation of cellular morphology
and nuclear staining pattern, which after a
moderate insult were no different from control
cells. Treatment with DPQ preserved cellular
and nuclear morphology to some extent also
when applied directly after a severe oxidative
insult (III, Fig. 3).
DNA-ladder formation by 24 h after a
moderate 60-min exposure to H2O2 (200 µM)
was markedly reduced by treatment with DPQ,
with a concomitant increase in the amount of
intact high molecular weight DNA. Treatment
of the severely exposed cells with DPQ was
associated with more marked low molecular
weight DNA-fragmentation and a relative
increase in the amount of high molecular
weight DNA, which resembled the pattern
observed after moderate exposure (III, Fig. 5).
Western blots of untreated control cells at 24 h
showed a single immunoreactive band of
PARP, which corresponded with the size of
the intact enzyme (116 kD) (Fig. 6). After a
moderate exposure to H2O2 (200 µM),
cleavage to one distinct larger and one smaller
fragment was detected.  Treatment of these
cells with the inhibitor of PARP, DPQ, did not
affect the cleavage pattern. After a severe
transient insult (1 mM H2O2), a single band,
corresponding to uncleaved PARP was
blotted. In these cells, cleavage of the protein
was seen following DPQ-treatment, also when
applied only after the insult.
13 EFFECTS OF EXTRACELLULAR
GLUCOSE ON OXIDANT-INDUCED
DAMAGE (IV)
13.1 Nucleotide depletion
Alteration of the extracellular glucose
concentration for 60 min to 0 mM or 33 mM
did not induce changes in ATP, adenine
nucleotides, or EC of the rat cortical neurons
prelabeled with 14C-adenine when compared
with cells cultured in 6 mM glucose. However,
the acute adenine nucleotide and EC depletion
caused by H2O2 were significantly more severe
when glucose was absent from the culture
medium (IV, Fig. 1). In contrast, increasing the
glucose concentration to 33 mM did not
modify the acute effects of H2O2. Exposure of
the cells to 5 mM 2-deoxyglucose for 60 min,
to transiently block glycolysis, led to a
significant acute depletion of ATP (54-61% of
control) and adenine nucleotides (68-70% of
control), unaffected by extracellular glucose
concentration.
13.2 Delayed effects of oxidant
exposure
The absence of glucose for 60 min did not
affect subsequent ATP nor adenine nucleotide
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synthesis from 14C-adenine over 24 h when
compared to untreated control neurons.
However, the incorporation of radioactive 14C-
adenine into cellular ATP and adenine
nucleotides of neurons exposed for 60 min to
200 µM H2O2 in the absence of glucose, and
then returned to culture conditions with
‘normal glucose’ for 24 h, was significantly
lower than in control cells (IV, Fig. 2). Despite
acute nucleotide depletion caused by blocking
of glycolysis, which was equivalent with that
induced by H2O2 in the absence of glucose, the
14C-adenine incorporation of rat cortical
neurons showed recovery at 12 h, and by 24 h
had returned to control values (IV, Fig. 3).
Mere temporary absence of glucose for 60 min
had no perceptible effects on cellular nor
nuclear morphology at 24 h (not shown). At 24
h, cells exposed to H2O2 in the presence of 6
mM glucose for 60 min were partially detached
from the culture dish and exhibited neurite
fragmentation (IV, Fig. 4, I B), and their nuclei
were shrunken and round (IV, Fig. 4, II B). In
the absence of glucose, a corresponding
transient oxidative insult caused substantial
deterioration of these changes, as the cells
appeared necrotic with severely deformed
somae, degradation of neurites (IV, Fig. 4, I
C), and inconsistently stained nuclei (IV, Fig. 4,
II C). Exposure to H2O2 in medium containing
33 mM glucose did not cause changes different
from those seen in ‘normal glucose’ neurons
(not shown). Transient blockade of glycolysis
by exposing the cells for 60 min to  5 mM
deoxyglucose, despite acute ATP depletion, did
not cause any detectable changes in cellular nor
nuclear morphology over the 24 h follow-up
(not shown).
Post–insult addition of 5 mM α−ketoglutarate
to the medium produced visible preservation
of neuronal morphology of  the cells exposed
to H2O2 in the presence of 6 mM glucose (IV,
Fig. 4, I D), while the recovery of the cells
exposed to H2O2 in the absence of glucose was
even more marked (IV, Fig. 4, I E). In the
latter, nuclear staining was enhanced and
comparable to that of the H2O2-exposed and
α−ketoglutarate-treated ‘normal glucose’
neurons, resembling the control cells as judged
by  their morphology or nuclear staining
pattern (IV, Fig. 4, II D-E). Post–insult
application of 5 mM pyruvate had only minor
effects on cellular (IV, Fig. 4, I F-G) and
nuclear morphology (IV, Fig. 4, II F-G).
A 60-min exposure to H2O2 reduced the cell
counts of both ‘normal glucose’ and ‘no
glucose’ groups at 24 h. However, the cell
counts of the H2O2-exposed cells were
significantly lower in the ‘no glucose’ group
than in ‘normal glucose’ neurons (IV, Fig. 5).
Post–insult treatment of the neurons with
α−ketoglutarate or pyruvate did not influence
the cell counts of normoglycemic cells,
whereas the cell counts of hypoglycemic
neurons were significantly improved by
α−ketoglutarate and, to some extent, by
pyruvate treatment (IV, Fig. 5). The number of
cells exposed to deoxyglucose, or to medium
containing no or high glucose for 60 min, did
not differ from untreated controls (data not
shown).
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DISCUSSION
We set up these experimental techniques to
evaluate, whether the severity of an acute
disturbance in energy metabolism caused by an
oxidative insult predicts the fate of the cells in
vitro, and to develop a model for exploring
methods of preventing cell damage. To further
clarify the role of apoptosis in oxidant-induced
cell death in our model, we used cultured
human cells of neural origin with a parallel line
overexpressing the anti-apoptotic protein Bcl-
2. We found that the acute disturbance of
cellular energy status, as reflected in EC,
correlated well with the potential of the cells to
survive after an oxidative insult. The degree of
the acute adenine nucleotide depletion was also
dependent on the intensity of the exposure but
predicted cell survival only in the wild type
cells. Bcl-2 did not protect against the fall in
EC or adenine nucleotide depletion, but
although survival was not improved, the
mechanism of death in these cells appeared to
be different.
Extending these observations to a model of
cultured primary neurons, we established that a
mild insult caused no changes in energy
metabolism nor cell survival, whereas after
moderate exposure, biphasic ATP depletion
and apoptotic cell death ensued. Severe
exposure led to irreversible ATP depletion and
necrotic cell death. Our model thus mimicked
the findings of in vivo studies in newborn
animals, in which severe asphyxia followed by
resuscitation produces a biphasic impairment
in cerebral oxidative phosphorylation, followed
by brain damage (Lorek et al. 1994, Penrice et
al. 1997). A similar continuum of cell fate from
no damage through apoptosis to necrosis has
been previously demonstrated in other cell
types (Lelli et al. 1998) after exposure to other
oxidants (Dypbukt et al. 1994), and after
exposure to NMDA (Bonfoco et al. 1995).
In addition to having anti-apoptotic properties,
Bcl-2 is an antioxidant (Hockenbery et al.
1993, Kane et al. 1993, Brucekeller et al. 1998).
The absence in our model of protective effect
by Bcl-2 against oxidant-induced adenine
nucleotide depletion but with modulation of
cell death characteristics is in agreement with a
gate-keeping mechanism to inhibit the
mitochondrial events associated with the onset
of apoptosis (Susin et al. 1996, Yang et al.
1997, Shimizu et al. 1999). These results are in
line also with previous data (Marton et al.
1997), which showed that Bcl-2
overexpression did not protect hematopoetic
cells from ATP depletion induced by
mitochondrial inhibitors, although it rescued
these cell from apoptosis. It has been
suggested that protection by Bcl-2
overexpression against oxidants, at least H2O2,
may be concentration-dependent or limited to
the apoptotic mode of death (Gardner et al.
1997, Lee and Shacter 1997). As all the criteria
of apoptosis were not fulfilled, we cannot be
certain that the death of our wild type cells was
apoptotic. The death of the Bcl-2
overexpressing cells in our model showed no
apoptotic features, but rather signs of delayed
necrosis. Our data were insufficient, however,
to clarify the exact mechanisms of death in
these cell lines. The fact that Bcl-2
overexpressing cells appeared, indeed, more
vulnerable to oxidative stress than the wild
type cells, may also partly be explained by the
redox-properties of the Bcl-family members
regulating the mitochondrial membrane
permeability and ATP production. It is
possible that the equilibrium between anti- and
proapoptotic bcl-2 members may have been
affected by direct oxidation (Harris and
Thompson 2000). The low-level constitutive
expression of Bcl-2 of the wild type cells and
the effects of H2O2 on this may have also
modified their mode of death. How the
properties of the Bcl-2 cells are related to their
differentiation stage remains an open, but
intriguing question.
Generation of reactive oxygen metabolites has
been clearly documented in the reperfused
brain of animals  after cerebral ischemia
(Armstead et al. 1988, Zini et al. 1992,
Hasegawa et al. 1993, Phillis and Sen 1993,
Hyslop et al. 1995, Bågenholm et al. 1998).
The role of ROS in the pathogenesis of
hypoxic-ischemic encephalopathy is supported
by the reduction of organ damage in stroke
models by antioxidant treatment (Palmer 1995,
Fellman and Raivio 1997), or by
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overexpression of mitochondrial MnSOD
dismutase (Chan et al. 1998, Keller et al. 1998).
The relevance of using H2O2, a freely diffusing
oxidant in vitro, is supported by detection by
microdialysis of concentrations of H2O2
around 100 µM  during the reperfusion period
after 30 min of in vivo forebrain ischemia in rat,
which results in a substantial neuronal loss at
24 h (Hyslop et al. 1995). Experimental
asphyxia increases H2O2-production also from
tissue granulocytes (Kutzche et al. 2001). In
vitro, H2O2 exposure is an effective inducer of
neuronal apoptosis (Whittemore et al. 1995).
The delayed ATP depletion in our model
coincided with delayed cell death displaying
apoptotic characteristics. This is in accordance
with another study using rat cortical neurons,
in which a brief exposure to 200 µM H2O2
induced a decrease in neuronal ATP contents
associated with increased apoptosis at 24 h
(Mailly et al. 1999).
ATP depletion may be due to decreased
synthesis, to increased utilization or
catabolism, or to efflux out of the cells.
Oxidant exposure results in rapid activation of
PARP, which is followed by depletion of
cellular NAD and ATP, influx of Ca2+ into the
cell, and potentially by lysis of the cell
(Schraufstatter et al. 1986). Acute oxidant
exposure may increase cellular permeability
and leakage of nucleotides (Aalto and Raivio
1993), but in our studies on rat cortical
neurons this only occurred at the highest H2O2
concentration used (data not shown). During
the secondary energy failure there was no
significant increase in the amount of
nucleotides recovered from the medium,
which would indicate cell membrane damage.
It thus seems  likely that the secondary ATP
depletion was due to increased catabolism,
shown by accumulation of hypoxanthine in the
medium, in combination with decreased
synthesis,  shown by decreased incorporation
of 14C-adenine with ATP. In spite of decreased
ATP synthesis, the EC remained normal in the
secondary stage of the energy failure, which
indicates a functional cytoplasmic adenylate
kinase. The possible causes for decreased ATP
synthesis are lack of the co-substrate 5-
phosphoribosyl-1-pyrophosphate, for adenine
salvage, or mitochondrial dysfunction, which
has been shown to be associated with neuronal
apoptosis induced by oxidants (Keller et al.
1998). The temporary recovery of ATP could
also in part be ascribed to the proteolytic
inactivation of the ATP consuming enzyme
PARP, an early committed step of apoptosis
(Lazebnik et al. 1994).
Using DPQ, a compound that specifically
inhibits PARP, we showed that the degree of
oxidant-induced ATP depletion and cell fate
can be modified, to some extent also when
applied after the insult. In cells exposed to
oxidants, overactivation of PARP has been
considered to be the key trigger of ATP
depletion and necrosis (Schraufstatter et al.
1986, Ha and Snyder 1999). The role of PARP
activation in ischemia-induced cerebral injury
is supported by the finding that PARP-
deficient mice are resistant to ischemia-induced
cerebral injury (Eliasson et al. 1997, Endres et
al. 1997). Oxidants may trigger apoptosis or
delayed cell death also by mechanisms
involving loss of mitochondrial membrane
potential, release of cytochrome c to activate
cytosolic caspases (Yang and Cortopassi 1998),
and translocation of apoptosis-inducing factor
(AIF) into the nucleus (Yu et al. 2002). The
role of cellular energy status and PARP in
these processes has not been fully clarified,
although it has been shown that translocation
of AIF is PARP-dependent.
In a cell exposed to oxidants, a moderate insult
associated with reversal of PARP activation
through cleavage by caspases may retain
sufficient NAD+ and ATP to allow energy-
dependent apoptosis to proceed (Coppola et
al. 1995, Herceg and Wang 1999). Upon severe
oxidant exposure, more rapid activation and
automodification of the enzyme by ADP-
ribosylation would render PARP uncleavable
by caspases while retaining enzymatic activity,
which would result in severe ATP depletion
and necrosis. This hypothesis is consistent
with our finding that an intact band of PARP
was detected after severe exposure, whereas a
moderate exposure yielded a pattern of cleaved
PARP. On the other hand, inhibiting PARP
during a severe necrosis-inducing insult
induced its cleavage.
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Neither PARP activation nor its cleavage are
essential for caspase-dependent apoptosis,
since this proceeds normally after induction by
TNF-α or anti-FAS in PARP-deficient cells.
Also, apoptosis is enhanced rather than
impeded in TNF-α-exposed fibroblasts
expressing a cleavage-resistant but active
mutant of PARP (Herceg and Wang 1999). It
has been suggested that in neurons PARP
activation is related only to the necrotic type of
cell death (Ha and Snyder 1999, Moroni et al.
2001). However, our findings, in accordance
with previous results (Cole and Perez-Polo
2002), suggest that, depending on the depth of
the initial exposure, oxidant-induced delayed
cell death can have apoptotic or necrotic
characteristics, and can be modified by  PARP
inhibition at any level of exposure, to some
extent also when applied as rescue treatment.
Although administration of DPQ did not fully
reverse nucleotide depletion and cell loss after
severe oxidant exposure, it clearly had a
salutary effect. This encourages the search for
clinical applications that, in combination with
controlling PARP overactivation, would aid
post-asphyxial neuronal ATP-synthesis.
Perinatal asphyxia is often complicated by
hypoglycemia, which may enhance
excitotoxicity (Wieloch 1985) and affect
reperfusion (Kim et al. 1994). Animal models
have shown that treatment of hypoglycemia by
overcompensating blood glucose levels can be
detrimental, as hyperglycemia may amplify the
effects of ischemia and the production of ROS
(Li et al. 2001, Russell et al. 2002). In our
model of combined oxidative stress and
hypoglycemia, the acute ATP depletion by
H2O2-exposure and its consequences were
markedly enhanced. Addition of a citric acid
cycle intermediate, α-ketoglutarate to the
culture medium after the exposure improved
neuronal morphology and viability at 24h
regardless of the extracellular glucose
concentration. The salutary effects were
particularly pronounced in the neurons
exposed in the absence of glucose, suggesting
that circumventing glycolysis, which requires
an investment of ATP and NAD+, can be of
benefit upon reperfusion. Supplementation
with pyruvate was not equally effective. Simple
short-term absence of glucose or mere acute
ATP depletion by inhibition of glycolysis had
no acute nor delayed effects in these cells,
underlining the fact that signaling for cell death
is independent of ATP depletion, although
often accompanying it.
Documentation of metabolic alterations by
MRS gives a composite picture of events in the
whole CNS, but does not allow conclusions
regarding different regions of the brain, nor
changes in neurons in comparison with other
cell types. The present models aimed at
focusing the studies on the metabolic
responses of neurons, although the possible
presence of a small percentage of other cell
types precludes definite conclusions. Neither
malignant neural crest-derived cells nor
primary embryonal neurons are an ideal model
to evaluate the process of oxidant-induced
injury in neural cells in vivo. The Paju cells,
however, offered a useful tool to assess the
mechanisms of oxidative injury, as they were
rather resistant to the acute toxicity of oxidants
and could thus be reliably analyzed and
followed up. Also, as the differentiation stage
of these cells could be modified in vitro, and as
they could be induced to overexpress a known
anti-apoptotic protein, they could be used as a
model to investigate the relations of oxidant
resistance to the stage of differentiation and
Bcl-2 expression. The results obtained using
cultured rat cortical neurons must also be
interpreted cautiously, in view of the limited
analogy to the complex interactions occurring
in the CNS during ischemia-reperfusion.
Nevertheless, the method of prelabeling the
cells with a high-energy nucleotide precursor
proved a sensitive tool for exploring the acute
and delayed effects of different exposures on
cellular energy metabolism in vitro.
The intracellular program for disposal of
damaged cells appears a complex web of
intertwining and complementary pathways.
There seem, however, to be several
checkpoints and determinants that can be
considered when aiming to modify or prevent
cell injury and delayed neuronal death.
However, as the immature CNS has
considerable capacity for plasticity and
regeneration, the most severely damaged
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neurons may most appropriately be disposed
of and compensated by their surviving
neighbors. Surviving but malfunctioning
neurons severely hinder the formation of
functional neuronal circuits. Therefore,
therapeutic interventions must be targeted not
only to the survival but also to the appropriate
functional recovery of the neurons. In
addition, bearing in mind the plasticity of an
immature CNS and the process of neuronal
maturation and development, an infant with
postasphyxial  HIE will be likely to benefit
especially much from occupational and
physical therapy.
In the sequence of events triggered by
perinatal asphyxia, there exists a ‘window of
opportunity’ during which it could be possible
to reverse or alleviate the extent of delayed
death of the immature neurons. As the cellular
energy status has an influence on the fate of
the cells, enhancing pathways to aid ATP
synthesis without causing excess burden by
ROS generation would be desirable. Whereas
both hypo- and hyperglycemia may be
detrimental to the immature CNS (Yager et al.
1992, LeBlanc et al. 1993), also other fuels to
supplement glucose could be considered upon
resuscitation. As some pharmaceutical
therapeutic pathways, e.g. iNOS inhibition and
treatment with free radical scavengers, along
with PARP inhibition, have shown promising,
but at most only partial neuroprotection, it
would be reasonable to continue to explore the
possibility to combine these strategies. This
model may therefore prove useful for further
investigating the roles played by events
associated with ischemia-reperfusion, the
possibilities of preventing the secondary
deterioration of neuronal energy metabolism,
and investigating the modifications caused by
neuronal-glial interactions.
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CONCLUSIONS
The present series of studies aimed at investigating the acute and delayed effects of a
transient oxidative exposure on cultured neuronal cells. Based on the results presented in
this thesis, the main conclusions are:
I     In a model of cultured human neural crest-derived tumor cells, the cellular energy
charge directly after a transient oxidative exposure correlates well with survival. In these
cells, an exposure that causes a significant decline in EC but does not affect immediate
viability, triggers a process of delayed cell death with apoptotic features. Neither the initial
drop in EC, adenine nucleotide depletion, nor cell death are inhibited by Bcl-2
overexpression. However, the characteristics of the ensuing cell death are different. This
suggests that it is possible to modify the delayed effects of an oxidant-induced insult on
energy metabolism and argues against a distinct anti-oxidative action of Bcl-2.
II   In rat cortical neurons, a transient oxidative exposure induces a dose-dependent
reduction in EC and ATP, which, at a moderate exposure level, temporarily recover but
show a secondary reduction after 24 h. This secondary depletion of cellular ATP is
associated with cell death with apoptotic features. A mild insult causes no changes in energy
metabolism or cell survival, whereas a large dose of H2O2 results in severe ATP depletion
and necrotic cell death. This is in analogy with findings in in vivo.
III   The degree of the acute adenine nucleotide depletion and the cell fate produced by
different levels of  transient oxidative insult can be modified by specific inhibition of the
enzyme PARP, to some extent also when applied as a rescue-treatment.
IV   The effects of a transient oxidative exposure on rat cortical neurons are substantially
enhanced by lack of extracellular glucose. Addition of a citric acid cycle intermediate, α-
ketoglutarate, to the culture medium after the exposure markedly improves cellular
morphology and viability. The salutary effects are particularly marked in the absence of
glucose. Administration of citric acid cycle intermediates after a transient ischemia
complicated by hypoglycemia could therefore be considered as a therapeutic approach.
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